Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes
Defense Response To Virus (GO:0051607),28/189,2.92871639469892e-29,1.50069846092918e-26,0,0,30.3162754905733,1991.79153114532,IFITM1;IFI6;DDX60L;IFIT1;DDX60;USP18;IFIT3;IFI44L;IFIT2;OASL;GBP2;GBP5;RSAD2;STAT1;MX2;MX1;EIF2AK2;ISG15;MID2;NT5C3A;PLSCR1;AIM2;IFI27;OAS1;OAS2;OAS3;IRF7;TLR7
Defense Response To Symbiont (GO:0140546),26/148,3.18958227615128e-29,1.50069846092918e-26,0,0,36.576051318603,2399.94045056508,IFITM1;IFI6;DDX60L;IFIT1;DDX60;IFIT3;IFI44L;IFIT2;OASL;GBP2;GBP5;RSAD2;STAT1;MX2;MX1;EIF2AK2;ISG15;NT5C3A;PLSCR1;AIM2;IFI27;OAS1;OAS2;OAS3;IRF7;TLR7
Negative Regulation Of Viral Process (GO:0048525),13/61,2.97262669418954e-16,9.32413906410785e-14,0,0,41.9178059895833,1498.64185840308,IFITM1;RSAD2;STAT1;MX1;EIF2AK2;ISG15;IFIT1;MID2;OASL;PLSCR1;OAS1;OAS2;OAS3
Negative Regulation Of Viral Genome Replication (GO:0045071),11/53,8.51777424909906e-14,2.00380639210055e-11,0,0,39.924358974359,1201.48510557652,IFITM1;PLSCR1;RSAD2;OAS1;OAS2;OAS3;MX1;EIF2AK2;ISG15;IFIT1;OASL
Regulation Of Viral Genome Replication (GO:0045069),11/67,1.32078202678612e-12,2.48571177441147e-10,0,0,29.9221153846154,818.453551224016,IFITM1;PLSCR1;RSAD2;OAS1;OAS2;OAS3;MX1;EIF2AK2;ISG15;IFIT1;OASL
Interleukin-27-Mediated Signaling Pathway (GO:0070106),5/5,1.62144027862437e-11,2.54295883697588e-09,0,0,99295,2466996.31032766,OAS1;OAS2;STAT1;MX1;OASL
Regulation Of Ribonuclease Activity (GO:0060700),4/5,1.1769696729902e-08,1.58218351754825e-06,0,0,579.795620437956,10585.756347343,OAS1;OAS2;OAS3;OASL
Response To Cytokine (GO:0034097),10/125,1.95667864147253e-08,2.30154325203206e-06,0,0,13.1058745436442,232.621832666812,IFITM1;PLSCR1;STAT1;LAMP3;MX2;MX1;EIF2AK2;ISG15;IL6ST;XAF1
Antiviral Innate Immune Response (GO:0140374),7/46,3.16989210544859e-08,3.30443792788224e-06,0,0,26.5480290853425,458.404372018004,OAS1;MX1;EIF2AK2;IFIT1;USP18;IFIT3;IFIT2
Regulation Of Nuclease Activity (GO:0032069),4/6,3.51162372782385e-08,3.30443792788224e-06,0,0,289.883211678832,4975.7300166713,OAS1;OAS2;OAS3;OASL
Response To Interferon-Beta (GO:0035456),6/29,4.58533484851575e-08,3.92254553859393e-06,0,0,38.3304347826087,647.700695853552,IFITM1;PLSCR1;AIM2;OAS1;STAT1;XAF1
Positive Regulation Of Interferon-Beta Production (GO:0032728),6/36,1.80551915043187e-07,1.41582793379699e-05,0,0,29.3762962962963,456.133022713597,OAS1;OAS2;OAS3;IRF7;ISG15;TLR7
Positive Regulation Of Type I Interferon Production (GO:0032481),7/64,3.31041491436381e-07,2.39623110339719e-05,0,0,18.1479444880859,270.785881096681,OAS1;OAS2;STAT1;OAS3;IRF7;TLR7;ISG15
Regulation Of Interferon-Beta Production (GO:0032648),6/50,1.35840014591278e-06,9.13038955217088e-05,0,0,20.0151515151515,270.388743172119,OAS1;OAS2;OAS3;IRF7;TLR7;ISG15
Cellular Response To Cytokine Stimulus (GO:0071345),12/308,1.94838966681006e-06,0.000122228978431218,0,0,6.14802011313639,80.8372875745205,GBP5;AIM2;OAS1;STAT1;ZC3H12A;IFIT1;IL6ST;GBP2;GBP1;TNFRSF21;LILRA4;GBP4
Negative Regulation Of Type I Interferon-Mediated Signaling Pathway (GO:0060339),4/15,3.04171453052916e-06,0.000178890835826746,0,0,52.6821499668215,669.226050867576,OAS1;OAS3;ISG15;USP18
Response To Interferon-Alpha (GO:0035455),4/17,5.24568303871204e-06,0.000290363984672237,0,0,44.5727119595733,541.919716505483,IFITM1;MX2;LAMP3;EIF2AK2
Cellular Response To Type I Interferon (GO:0071357),5/38,6.75067944644404e-06,0.000352910519950214,0,0,22.0877896613191,262.974294853793,IFITM1;IFI27;STAT1;OAS2;IFIT1
Response To Type II Interferon (GO:0034341),6/80,2.16015617189615e-05,0.000969400863843521,0,0,11.8828828828829,127.654780011233,GBP5;IFITM1;STAT1;GBP2;GBP1;GBP4
Positive Regulation Of Immune Response (GO:0050778),6/80,2.16015617189615e-05,0.000969400863843521,0,0,11.8828828828829,127.654780011233,GBP5;PLSCR1;ITGAM;RSAD2;IFI35;IL6ST
Cellular Response To Tumor Necrosis Factor (GO:0071356),7/119,2.16338131144675e-05,0.000969400863843521,0,0,9.21035447761194,98.9307480809769,AIM2;TRAF4;STAT1;ZC3H12A;GBP2;GBP1;TNFRSF21
Response To Type I Interferon (GO:0034340),3/9,2.7930702497252e-05,0.00119467232045064,0,0,71.9311594202899,754.254602439332,MX1;ISG15;IFIT1
Regulation Of Interferon-Alpha Production (GO:0032647),4/26,3.13661818440529e-05,0.00128328596153277,0,0,26.3264764432648,272.999775651936,STAT1;IRF7;TLR7;LILRA4
Regulation Of Type I Interferon-Mediated Signaling Pathway (GO:0060338),4/33,8.26288349277888e-05,0.00323973890279372,0,0,19.9647621444752,187.691760513841,OAS1;OAS3;ISG15;USP18
Cytokine-Mediated Signaling Pathway (GO:0019221),9/257,8.89361544850691e-05,0.003347556854818,0,0,5.39158724340176,50.2905250198359,AIM2;TRAF4;OAS1;OAS2;STAT1;MX1;IL6ST;LILRA4;OASL
Cellular Response To Type II Interferon (GO:0071346),5/66,0.000102606825145882,0.00371357778701057,0,0,11.932256509161,109.593075987034,GBP5;STAT1;GBP2;GBP1;GBP4
Type I Interferon-Mediated Signaling Pathway (GO:0060337),4/37,0.000130480644102784,0.00454749207780443,0,0,17.5412519354125,156.89396820143,IFITM1;IFI27;STAT1;OAS2
Defense Response To Protozoan (GO:0042832),3/15,0.000146667586334066,0.00492907852644129,0,0,35.9547101449275,317.384517541058,GBP2;GBP1;GBP4
Positive Regulation Of Pattern Recognition Receptor Signaling Pathway (GO:0062208),4/39,0.000160733035934294,0.00521550989014381,0,0,16.5372262773723,144.465334602153,RSAD2;IFI35;DDX60;OASL
Interferon-Mediated Signaling Pathway (GO:0140888),4/49,0.000392069220317913,0.0122979045439719,0,0,12.855798864558,100.841813856438,IFITM1;IFI27;OAS2;STAT1
Positive Regulation Of Interferon-Alpha Production (GO:0032727),3/21,0.00041563962335457,0.012616673728279,0,0,23.9625603864734,186.565113817753,STAT1;IRF7;TLR7
Cellular Response To Interferon-Beta (GO:0035458),3/22,0.000478790424052386,0.0140536572289965,0,0,22.7002288329519,173.526169420963,AIM2;OAS1;STAT1
Negative Regulation Of Innate Immune Response (GO:0045824),4/52,0.000492848765735264,0.0140536572289965,0,0,12.0504866180049,91.76816948616,OAS1;OAS3;ISG15;USP18
Positive Regulation Of Chemokine Production (GO:0032722),4/53,0.000530187147631761,0.0146737089976908,0,0,11.8039624608968,89.028795950658,OAS1;OAS3;EIF2AK2;TLR7
Defense Response To Bacterium (GO:0042742),7/204,0.000618664974689639,0.0166332497480843,0,0,5.21380407606637,38.5193064522482,OAS1;OAS2;OAS3;ISG15;GBP2;GBP1;GBP4
Regulation Of Toll-Like Receptor 7 Signaling Pathway (GO:0034155),2/6,0.00072665336011909,0.0189939114408907,0,0,71.4208633093525,516.162936007876,RSAD2;LILRA4
Negative Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001960),4/59,0.000797585434199755,0.0202845376643776,0,0,10.5130723291307,74.9994337871259,OAS1;OAS3;ISG15;USP18
Positive Regulation Of Defense Response To Virus By Host (GO:0002230),3/28,0.000987505924782035,0.0238217244503342,0,0,17.2469565217391,119.354597191615,STAT1;ZC3H12A;PARP9
Cellular Modified Amino Acid Biosynthetic Process (GO:0042398),2/7,0.0010126131541056,0.0238217244503342,0,0,57.1338129496403,393.950267322451,GATM;PLSCR1
Positive Regulation Of Isomerase Activity (GO:0010912),2/7,0.0010126131541056,0.0238217244503342,0,0,57.1338129496403,393.950267322451,PLSCR1;ITGAM
Positive Regulation Of Monocyte Chemotactic Protein-1 Production (GO:0071639),2/8,0.00134391398963612,0.0308444649816485,0,0,47.6091127098321,314.799500831182,OAS1;OAS3
Positive Regulation Of RIG-I Signaling Pathway (GO:1900246),2/9,0.00171991149404869,0.0385342075214243,0,0,40.8057553956835,259.748319684505,DDX60;OASL
Positive Regulation Of Lymphocyte Proliferation (GO:0050671),4/74,0.00185873802489588,0.0399118719615936,0,0,8.25401459854015,51.9000676213902,CD70;CD38;IL6ST;TNFSF13B
Positive Regulation Of Defense Response (GO:0031349),5/124,0.00186622993231681,0.0399118719615936,0,0,6.09861591695502,38.3226959194636,GBP5;PLSCR1;AIM2;TLR7;IFI35
Regulation Of Tumor Necrosis Factor Production (GO:0032680),5/127,0.00207222302640123,0.0433324859520791,0,0,5.94774590163934,36.7519148925183,OAS1;OAS2;OAS3;ZC3H12A;LILRA4
Regulation Of Toll-Like Receptor 9 Signaling Pathway (GO:0034163),2/10,0.00213996800643932,0.0437763020447695,0,0,35.7032374100719,219.466529335962,RSAD2;LILRA4
Regulation Of Defense Response To Virus By Host (GO:0050691),3/37,0.00223625336005114,0.0442049074132472,0,0,12.675831202046,77.3600073935287,STAT1;ZC3H12A;PARP9
Regulation Of Innate Immune Response (GO:0045088),4/78,0.00225487306677563,0.0442049074132472,0,0,7.80627342671138,47.5765948717235,GBP5;PLSCR1;IFI35;PARP9
Tumor Necrosis Factor-Mediated Signaling Pathway (GO:0033209),3/38,0.00241550124859239,0.0463874831617437,0,0,12.3130434782609,74.1965340452092,AIM2;TRAF4;STAT1
Regulation Of Monocyte Chemotactic Protein-1 Production (GO:0071637),2/11,0.00260345251801356,0.0489969763890152,0,0,31.7346123101519,188.850038276729,OAS1;OAS3
Regulation Of NIK/NF-kappaB Signaling (GO:1901222),4/83,0.00282733111105639,0.0521670308922365,0,0,7.31035757183775,42.9002638062431,ZC3H12A;EIF2AK2;TLR7;IFI35
Positive Regulation Of Response To Biotic Stimulus (GO:0002833),3/41,0.00300569120518998,0.0543914504631495,0,0,11.3392448512586,65.8498037985506,GBP5;PLSCR1;IFI35
Regulation Of Chemokine (C-X-C Motif) Ligand 2 Production (GO:2000341),2/12,0.00310974061302506,0.0552125644689921,0,0,28.5597122302158,164.881386473093,OAS1;OAS3
Endolysosomal Toll-Like Receptor Signaling Pathway (GO:0140894),2/13,0.00365821440947843,0.0617918106890901,0,0,25.9620667102682,145.667447691008,OAS1;TLR7
Regulation Of ERBB Signaling Pathway (GO:1901184),2/13,0.00365821440947843,0.0617918106890901,0,0,25.9620667102682,145.667447691008,MVB12B;IFI6
Regulation Of B Cell Proliferation (GO:0030888),3/44,0.00367730223016902,0.0617918106890901,0,0,10.507953340403,58.9031298485145,CD38;TNFRSF21;TNFSF13B
Positive Regulation Of Innate Immune Response (GO:0045089),3/45,0.0039198399972084,0.0638926546510612,0,0,10.2572463768116,56.8426278198505,GBP5;PLSCR1;IFI35
Regulation Of RNA Metabolic Process (GO:0051252),4/91,0.00393812324097933,0.0638926546510612,0,0,6.63545599463042,36.7408582766187,OAS1;OAS2;OAS3;OASL
Positive Regulation Of Response To External Stimulus (GO:0032103),5/155,0.00487016572823067,0.0752688914170582,0,0,4.83063725490196,25.7213430619565,GBP5;PLSCR1;AIM2;TLR7;IFI35
Regulation Of Monocyte Differentiation (GO:0045655),2/15,0.00487927988994745,0.0752688914170582,0,0,21.9656889872717,116.918038732988,CDK6;IRF7
Positive Regulation Of Potassium Ion Transport (GO:0043268),2/15,0.00487927988994745,0.0752688914170582,0,0,21.9656889872717,116.918038732988,KCNH2;KCNN4
Regulation Of Nucleocytoplasmic Transport (GO:0046822),2/16,0.00555066794361625,0.0814224046313477,0,0,20.3956834532374,105.931855528266,IFI27;MX2
Cellular Response To Fatty Acid (GO:0071398),2/16,0.00555066794361625,0.0814224046313477,0,0,20.3956834532374,105.931855528266,IRS1;ZC3H12A
Negative Regulation Of Chemokine Production (GO:0032682),2/16,0.00555066794361625,0.0814224046313477,0,0,20.3956834532374,105.931855528266,OAS1;OAS3
Apoptotic Process (GO:0006915),6/228,0.0056242893741101,0.0814224046313477,0,0,3.93133133133133,20.3668936182604,PLSCR1;IFI27;MX1;IFI6;TNFRSF21;IFIT2
Positive Regulation Of NIK/NF-kappaB Signaling (GO:1901224),3/53,0.00621179153066773,0.0861436679476963,0,0,8.61260869565217,43.7632996671967,EIF2AK2;TLR7;IFI35
Regulation Of Hematopoietic Progenitor Cell Differentiation (GO:1901532),2/17,0.00626183432443953,0.0861436679476963,0,0,19.0350119904077,96.5699858653733,MYB;EIF2AK2
Positive Regulation Of Potassium Ion Transmembrane Transport (GO:1901381),2/17,0.00626183432443953,0.0861436679476963,0,0,19.0350119904077,96.5699858653733,KCNH2;KCNN4
Positive Regulation Of Inflammatory Response (GO:0050729),4/104,0.00631659201741875,0.0861436679476963,0,0,5.76905109489051,29.2177945681381,AIM2;TLR7;IFI35;IL6ST
Positive Regulation Of Stress-Activated MAPK Cascade (GO:0032874),4/105,0.00653149690287769,0.0878019797943987,0,0,5.71164269711643,28.7359548213098,TRAF4;ZC3H12A;EIF2AK2;WNT16
Negative Regulation Of Viral Entry Into Host Cell (GO:0046597),2/18,0.00701219293453115,0.0879796473519175,0,0,17.8444244604317,88.5102153729256,IFITM1;MID2
Positive Regulation Of Cation Transmembrane Transport (GO:1904064),2/18,0.00701219293453115,0.0879796473519175,0,0,17.8444244604317,88.5102153729256,KCNH2;KCNN4
Response To Organophosphorus (GO:0046683),2/18,0.00701219293453115,0.0879796473519175,0,0,17.8444244604317,88.5102153729256,STAT1;TLR7
Regulation Of RIG-I Signaling Pathway (GO:0039535),2/18,0.00701219293453115,0.0879796473519175,0,0,17.8444244604317,88.5102153729256,DDX60;OASL
Regulation Of Adaptive Immune Response (GO:0002819),2/18,0.00701219293453115,0.0879796473519175,0,0,17.8444244604317,88.5102153729256,IRF7;IL6ST
Response To Tumor Necrosis Factor (GO:0034612),4/108,0.00720517406908365,0.089211431565891,0,0,5.54604154969118,27.35837833061,ZC3H12A;GBP2;GBP1;TNFRSF21
Negative Regulation Of Viral Life Cycle (GO:1903901),2/20,0.00862817331575207,0.104091167822086,0,0,15.8601119104716,75.3787101436077,IFITM1;MID2
Regulation Of Toll-Like Receptor Signaling Pathway (GO:0034121),2/20,0.00862817331575207,0.104091167822086,0,0,15.8601119104716,75.3787101436077,GFI1;IRF7
Modulation By Host Of Viral Genome Replication (GO:0044827),2/21,0.00949265358180379,0.11170791974357,0,0,15.0246118894358,69.9731797049109,IFI27;ZC3H12A
Cellular Response To Oxidative Stress (GO:0034599),4/117,0.00949695385705168,0.11170791974357,0,0,5.10199599509076,23.7588942283003,ZC3H12A;MGAT3;AGAP3;WNT16
Negative Regulation Of Myeloid Cell Differentiation (GO:0045638),2/22,0.0103940429573733,0.119867988295345,0,0,14.2726618705036,65.1764305603726,CDK6;MYB
Cellular Response To Virus (GO:0098586),3/64,0.0104454570034201,0.119867988295345,0,0,7.05559515324305,32.1847191124888,OAS1;ZC3H12A;IFI6
Cytosolic Pattern Recognition Receptor Signaling Pathway (GO:0002753),2/23,0.0113317856979791,0.128472413756607,0,0,13.5923261390887,60.89557307559,OAS3;IRF7
Response To Purine-Containing Compound (GO:0014074),2/24,0.0123053319610333,0.136227263239204,0,0,12.9738391105298,57.0553456956556,STAT1;TLR7
Gliogenesis (GO:0042063),2/24,0.0123053319610333,0.136227263239204,0,0,12.9738391105298,57.0553456956556,CDK6;HAPLN3
Negative Regulation Of Epithelial Cell Proliferation (GO:0050680),3/70,0.0133114890465465,0.145652455730236,0,0,6.42180402336145,27.7365921457792,CDK6;STAT1;BRCA2
Cellular Response To Xenobiotic Stimulus (GO:0071466),2/26,0.0143576648872477,0.153529121123865,0,0,11.8914868105516,50.4611834811889,KCNH2;AIM2
Negative Regulation Of Catalytic Activity (GO:0043086),2/26,0.0143576648872477,0.153529121123865,0,0,11.8914868105516,50.4611834811889,IFIT1;PARP9
Antigen Receptor-Mediated Signaling Pathway (GO:0050851),4/134,0.0150170512592685,0.158775789156985,0,0,4.43099382369455,18.6038331871593,BTNL9;ZC3H12A;CD38;TNFRSF21
Negative Regulation Of NIK/NF-kappaB Signaling (GO:1901223),2/27,0.015435380899422,0.161385482515068,0,0,11.4152517985612,47.6140762274156,ZC3H12A;IFI35
Protein Localization To Organelle (GO:0033365),4/137,0.0161628238670893,0.167134255592648,0,0,4.3303880138302,17.8630302547479,GBP5;ISG15;GBP2;GBP1
Regulation Of Immune Response (GO:0050776),3/77,0.0171679635636067,0.1737102549823,0,0,5.81227967097532,23.625232553605,PLSCR1;RSAD2;IRF7
Regulation Of T Cell Proliferation (GO:0042129),3/77,0.0171679635636067,0.1737102549823,0,0,5.81227967097532,23.625232553605,CD70;IL6ST;TNFRSF21
Positive Regulation Of B Cell Proliferation (GO:0030890),2/29,0.0176912781257898,0.175961933540979,0,0,10.5686117772449,42.641003789163,CD38;TNFSF13B
Positive Regulation Of Tumor Necrosis Factor Production (GO:0032760),3/78,0.0177644885083879,0.175961933540979,0,0,5.73449275362319,23.1131818001584,OAS1;OAS2;OAS3
Cellular Response To Interleukin-1 (GO:0071347),3/81,0.0196228583831583,0.1903335312984,0,0,5.51309921962096,21.672324635552,ZC3H12A;GBP2;GBP1
Negative Regulation Of NF-kappaB Transcription Factor Activity (GO:0032088),3/81,0.0196228583831583,0.1903335312984,0,0,5.51309921962096,21.672324635552,AIM2;GFI1;ZC3H12A
Regulation Of Cell Population Proliferation (GO:0042127),11/766,0.0198221956081224,0.1903335312984,0,0,2.141049414162,8.39495407824413,IFITM1;CDK6;IRS1;STAT1;EIF2AK2;SGK3;IFI35;IL6ST;IER5;SOX7;IFIT3
Positive Regulation Of Tumor Necrosis Factor Superfamily Cytokine Production (GO:1903557),3/82,0.0202652845371817,0.192622553025132,0,0,5.44303797468354,21.2215667166879,OAS1;OAS2;OAS3
Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043281),3/84,0.0215846373266912,0.201100432915014,0,0,5.30810520665593,20.3606890332547,LAMP3;IFI6;SOX7
Regulation Of Interleukin-1 Beta Production (GO:0032651),3/84,0.0215846373266912,0.201100432915014,0,0,5.30810520665593,20.3606890332547,GBP5;AIM2;ZC3H12A
Regulation Of Osteoblast Differentiation (GO:0045667),3/85,0.0222615722451515,0.202454232317091,0,0,5.24310710498409,19.9494631194206,IFITM1;CDK6;IL6ST
Response To Interleukin-1 (GO:0070555),3/85,0.0222615722451515,0.202454232317091,0,0,5.24310710498409,19.9494631194206,ZC3H12A;GBP2;GBP1
Regulation Of Potassium Ion Transmembrane Transport (GO:1901379),2/33,0.0225905360183789,0.202454232317091,0,0,9.203063355767,34.8816736352706,KCNH2;KCNN4
Regulation Of NLRP3 Inflammasome Complex Assembly (GO:1900225),2/33,0.0225905360183789,0.202454232317091,0,0,9.203063355767,34.8816736352706,GBP5;EIF2AK2
Regulation Of Type II Interferon Production (GO:0032649),3/87,0.0236499651188928,0.208180014595282,0,0,5.11775362318841,19.1628841122957,ZC3H12A;TLR7;ISG15
Apoptotic Mitochondrial Changes (GO:0008637),2/34,0.0238931366379282,0.208180014595282,0,0,8.91501798561151,33.2901394997908,IFI6;IFIT2
Regulation Of T Cell Receptor Signaling Pathway (GO:0050856),2/34,0.0238931366379282,0.208180014595282,0,0,8.91501798561151,33.2901394997908,KCNN4;GBP1
Macrophage Activation (GO:0042116),2/35,0.0252258668843831,0.215795824892768,0,0,8.64442991061696,31.8105109634294,ITGAM;IFI35
Regulation Of G2/M Transition Of Mitotic Cell Cycle (GO:0010389),2/35,0.0252258668843831,0.215795824892768,0,0,8.64442991061696,31.8105109634294,CDK6;TNFSF13B
Positive Regulation Of Cytokine Production (GO:0001819),6/320,0.0260650343712895,0.220965741832283,0,0,2.76645435244161,10.0897031557098,GBP5;IRF7;EIF2AK2;ISG15;TLR7;IL6ST
Regulation Of Erythrocyte Differentiation (GO:0045646),2/36,0.0265882436353675,0.223388725543579,0,0,8.38975878121033,30.4320556568226,CDK6;STAT1
Negative Regulation Of Type I Interferon Production (GO:0032480),2/38,0.0294000302372037,0.239023846410982,0,0,7.9228617106315,27.9420284085746,XAF1;LILRA4
Response To Peptide (GO:1901652),2/38,0.0294000302372037,0.239023846410982,0,0,7.9228617106315,27.9420284085746,IRS1;STAT1
T Cell Receptor Signaling Pathway (GO:0050852),3/95,0.0296631305455067,0.239023846410982,0,0,4.67084120982987,16.4313206188862,BTNL9;ZC3H12A;TNFRSF21
Regulation Of Cytokine Production (GO:0001817),4/167,0.0306628227250896,0.239023846410982,0,0,3.52801038914513,12.2940731300671,BTNL9;IRF7;EIF2AK2;ISG15
Negative Regulation Of Protein Secretion (GO:0050709),2/39,0.0308484997885469,0.239023846410982,0,0,7.70834143496014,26.8147542004146,RSAD2;IRS1
Positive Regulation Of Protein-Containing Complex Assembly (GO:0031334),3/98,0.0321068632589342,0.239023846410982,0,0,4.52265446224256,15.5519861535328,GBP5;ISG15;GBP2
Regulation Of Chemokine Production (GO:0032642),2/41,0.0338282788377631,0.239023846410982,0,0,7.31230400295148,24.7628116636632,EIF2AK2;TLR7
CD4-positive, Alpha-Beta T Cell Activation (GO:0035710),1/5,0.0347596941750011,0.239023846410982,0,0,35.4553571428571,119.10506697069,RSAD2
ISG15-protein Conjugation (GO:0032020),1/5,0.0347596941750011,0.239023846410982,0,0,35.4553571428571,119.10506697069,ISG15
Negative Regulation Of Myeloid Cell Apoptotic Process (GO:0033033),1/5,0.0347596941750011,0.239023846410982,0,0,35.4553571428571,119.10506697069,IRF7
Negative Regulation Of Nervous System Process (GO:0031645),1/5,0.0347596941750011,0.239023846410982,0,0,35.4553571428571,119.10506697069,TNFRSF21
Regulation Of Hematopoietic Stem Cell Proliferation (GO:1902033),1/5,0.0347596941750011,0.239023846410982,0,0,35.4553571428571,119.10506697069,EIF2AK2
T-helper 2 Cell Differentiation (GO:0045064),1/5,0.0347596941750011,0.239023846410982,0,0,35.4553571428571,119.10506697069,MYB
Regulation Of Macrophage Apoptotic Process (GO:2000109),1/5,0.0347596941750011,0.239023846410982,0,0,35.4553571428571,119.10506697069,IRF7
Negative Regulation Of Vitamin Metabolic Process (GO:0046137),1/5,0.0347596941750011,0.239023846410982,0,0,35.4553571428571,119.10506697069,GFI1
Attachment Of GPI Anchor To Protein (GO:0016255),1/5,0.0347596941750011,0.239023846410982,0,0,35.4553571428571,119.10506697069,PGAP1
Regulation Of Protein Deubiquitination (GO:0090085),1/5,0.0347596941750011,0.239023846410982,0,0,35.4553571428571,119.10506697069,ZC3H12A
Response To cGMP (GO:0070305),1/5,0.0347596941750011,0.239023846410982,0,0,35.4553571428571,119.10506697069,TLR7
Establishment Of Protein Localization To Telomere (GO:0070200),1/5,0.0347596941750011,0.239023846410982,0,0,35.4553571428571,119.10506697069,BRCA2
Positive Regulation Of Interleukin-18 Production (GO:0032741),1/5,0.0347596941750011,0.239023846410982,0,0,35.4553571428571,119.10506697069,GBP5
Positive Regulation Of Toll-Like Receptor 7 Signaling Pathway (GO:0034157),1/5,0.0347596941750011,0.239023846410982,0,0,35.4553571428571,119.10506697069,RSAD2
Mesenchymal Cell Differentiation Involved In Kidney Development (GO:0072161),1/5,0.0347596941750011,0.239023846410982,0,0,35.4553571428571,119.10506697069,STAT1
Regulation Of Calcidiol 1-Monooxygenase Activity (GO:0060558),1/5,0.0347596941750011,0.239023846410982,0,0,35.4553571428571,119.10506697069,GFI1
Negative Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043124),2/42,0.0353586784005464,0.239023846410982,0,0,7.12913669064748,23.8270820441245,STAT1;ZC3H12A
Negative Regulation Of Cellular Process (GO:0048523),8/537,0.0366604730105512,0.239023846410982,0,0,2.19793339681908,7.2664911887214,IFITM1;CDK6;EIF2AK2;IFI35;WNT16;SOX7;IFIT3;TNFRSF21
Negative Regulation Of BMP Signaling Pathway (GO:0030514),2/43,0.0369154862859518,0.239023846410982,0,0,6.95490436918758,22.9450928500958,GPR155;SKIL
Negative Regulation Of Cytokine Production (GO:0001818),4/178,0.0374198215552743,0.239023846410982,0,0,3.30312945716923,10.8526126013893,ZC3H12A;XAF1;GBP1;TNFRSF21
Regulation Of Viral Entry Into Host Cell (GO:0046596),2/44,0.0384982598733763,0.239023846410982,0,0,6.78896882494005,22.1126371040578,IFITM1;MID2
Positive Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001961),2/44,0.0384982598733763,0.239023846410982,0,0,6.78896882494005,22.1126371040578,GFI1;PARP9
Positive Regulation Of Osteoblast Differentiation (GO:0045669),2/44,0.0384982598733763,0.239023846410982,0,0,6.78896882494005,22.1126371040578,IFITM1;IL6ST
Negative Regulation Of Hematopoietic Progenitor Cell Differentiation (GO:1901533),1/6,0.0415663206424517,0.239023846410982,0,0,28.3628571428571,90.2070755648637,MYB
Regulation Of Glial Cell Differentiation (GO:0045685),1/6,0.0415663206424517,0.239023846410982,0,0,28.3628571428571,90.2070755648637,TNFRSF21
RIG-I Signaling Pathway (GO:0039529),1/6,0.0415663206424517,0.239023846410982,0,0,28.3628571428571,90.2070755648637,OAS3
Regulation Of Hemoglobin Biosynthetic Process (GO:0046984),1/6,0.0415663206424517,0.239023846410982,0,0,28.3628571428571,90.2070755648637,EIF2AK2
Regulation Of Potassium Ion Export Across Plasma Membrane (GO:1903764),1/6,0.0415663206424517,0.239023846410982,0,0,28.3628571428571,90.2070755648637,KCNH2
Cellular Response To Interleukin-9 (GO:0071355),1/6,0.0415663206424517,0.239023846410982,0,0,28.3628571428571,90.2070755648637,STAT1
Response To Lead Ion (GO:0010288),1/6,0.0415663206424517,0.239023846410982,0,0,28.3628571428571,90.2070755648637,PLSCR1
Dense Core Granule Cytoskeletal Transport (GO:0099519),1/6,0.0415663206424517,0.239023846410982,0,0,28.3628571428571,90.2070755648637,KIF1C
Toll-Like Receptor 3 Signaling Pathway (GO:0034138),1/6,0.0415663206424517,0.239023846410982,0,0,28.3628571428571,90.2070755648637,OAS1
Glandular Epithelial Cell Development (GO:0002068),1/6,0.0415663206424517,0.239023846410982,0,0,28.3628571428571,90.2070755648637,CDK6
Type B Pancreatic Cell Development (GO:0003323),1/6,0.0415663206424517,0.239023846410982,0,0,28.3628571428571,90.2070755648637,CDK6
Histidine Catabolic Process (GO:0006548),1/6,0.0415663206424517,0.239023846410982,0,0,28.3628571428571,90.2070755648637,CARNS1
Histidine Metabolic Process (GO:0006547),1/6,0.0415663206424517,0.239023846410982,0,0,28.3628571428571,90.2070755648637,CARNS1
Interleukin-9-Mediated Signaling Pathway (GO:0038113),1/6,0.0415663206424517,0.239023846410982,0,0,28.3628571428571,90.2070755648637,STAT1
Keratinocyte Proliferation (GO:0043616),1/6,0.0415663206424517,0.239023846410982,0,0,28.3628571428571,90.2070755648637,WNT16
Macrophage Derived Foam Cell Differentiation (GO:0010742),1/6,0.0415663206424517,0.239023846410982,0,0,28.3628571428571,90.2070755648637,STAT1
Monoacylglycerol Catabolic Process (GO:0052651),1/6,0.0415663206424517,0.239023846410982,0,0,28.3628571428571,90.2070755648637,ABHD6
Regulation Of MDA-5 Signaling Pathway (GO:0039533),1/6,0.0415663206424517,0.239023846410982,0,0,28.3628571428571,90.2070755648637,DDX60
Negative Regulation Of T-helper 17 Type Immune Response (GO:2000317),1/6,0.0415663206424517,0.239023846410982,0,0,28.3628571428571,90.2070755648637,ZC3H12A
Regulation Of Cytokine Production Involved In Inflammatory Response (GO:1900015),2/46,0.0417399577701047,0.239023846410982,0,0,6.47972531066056,20.5815281064194,GBP5;ZC3H12A
Regulation Of Epidermal Growth Factor Receptor Signaling Pathway (GO:0042058),2/46,0.0417399577701047,0.239023846410982,0,0,6.47972531066056,20.5815281064194,MVB12B;IFI6
Regulation Of Interleukin-10 Production (GO:0032653),2/46,0.0417399577701047,0.239023846410982,0,0,6.47972531066056,20.5815281064194,ISG15;TNFRSF21
Negative Regulation Of Tumor Necrosis Factor Production (GO:0032720),2/47,0.0433980208753288,0.239023846410982,0,0,6.33541167066347,19.8763495793219,ZC3H12A;LILRA4
Cognition (GO:0050890),2/47,0.0433980208753288,0.239023846410982,0,0,6.33541167066347,19.8763495793219,MGAT3;GPR155
Insulin Receptor Signaling Pathway (GO:0008286),2/47,0.0433980208753288,0.239023846410982,0,0,6.33541167066347,19.8763495793219,IRS1;GAB1
Positive Regulation Of Reactive Oxygen Species Metabolic Process (GO:2000379),2/48,0.0450803271659638,0.239023846410982,0,0,6.19737253675321,19.2075745394213,ITGAM;ZC3H12A
Ubiquitin-Dependent Protein Catabolic Process (GO:0006511),6/367,0.0458796619865015,0.239023846410982,0,0,2.40049245921822,7.3976776778066,HERC5;IFI27;MVB12B;AGAP3;HERC6;TNFSF13B
Negative Regulation Of Tumor Necrosis Factor Superfamily Cytokine Production (GO:1903556),2/49,0.046786457812908,0.239023846410982,0,0,6.06520740854125,18.5726445001294,ZC3H12A;LILRA4
Neurogenesis (GO:0022008),2/49,0.046786457812908,0.239023846410982,0,0,6.06520740854125,18.5726445001294,CDK6;BTBD3
Positive Regulation Of miRNA Metabolic Process (GO:2000630),2/49,0.046786457812908,0.239023846410982,0,0,6.06520740854125,18.5726445001294,MYB;ZC3H12A
Negative Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043154),2/49,0.046786457812908,0.239023846410982,0,0,6.06520740854125,18.5726445001294,LAMP3;IFI6
Modification-Dependent Protein Catabolic Process (GO:0019941),4/192,0.0471637738264997,0.239023846410982,0,0,3.05497748097531,9.33029588339527,HERC5;ISG15;HERC6;TNFSF13B
Regulation Of Chemokine (C-C Motif) Ligand 5 Production (GO:0071649),1/7,0.0483252883534015,0.239023846410982,0,0,23.6345238095238,71.6078870198875,OAS3
Regulation Of Dopamine Metabolic Process (GO:0042053),1/7,0.0483252883534015,0.239023846410982,0,0,23.6345238095238,71.6078870198875,ITGAM
Negative Regulation Of Monooxygenase Activity (GO:0032769),1/7,0.0483252883534015,0.239023846410982,0,0,23.6345238095238,71.6078870198875,GFI1
Negative Regulation Of Nitric Oxide Biosynthetic Process (GO:0045019),1/7,0.0483252883534015,0.239023846410982,0,0,23.6345238095238,71.6078870198875,ZC3H12A
Negative Regulation Of Nitric Oxide Metabolic Process (GO:1904406),1/7,0.0483252883534015,0.239023846410982,0,0,23.6345238095238,71.6078870198875,ZC3H12A
Negative Regulation Of Osteoblast Proliferation (GO:0033689),1/7,0.0483252883534015,0.239023846410982,0,0,23.6345238095238,71.6078870198875,EIF2AK2
Regulation Of Myeloid Leukocyte Differentiation (GO:0002761),1/7,0.0483252883534015,0.239023846410982,0,0,23.6345238095238,71.6078870198875,IRF7
Plasma Membrane Phospholipid Scrambling (GO:0017121),1/7,0.0483252883534015,0.239023846410982,0,0,23.6345238095238,71.6078870198875,PLSCR1
Positive Regulation Of T-helper 2 Cell Cytokine Production (GO:2000553),1/7,0.0483252883534015,0.239023846410982,0,0,23.6345238095238,71.6078870198875,RSAD2
Positive Regulation Of Execution Phase Of Apoptosis (GO:1900119),1/7,0.0483252883534015,0.239023846410982,0,0,23.6345238095238,71.6078870198875,ZC3H12A
Stress-Induced Premature Senescence (GO:0090400),1/7,0.0483252883534015,0.239023846410982,0,0,23.6345238095238,71.6078870198875,WNT16
Sulfur Amino Acid Transport (GO:0000101),1/7,0.0483252883534015,0.239023846410982,0,0,23.6345238095238,71.6078870198875,SLC7A11
Foam Cell Differentiation (GO:0090077),1/7,0.0483252883534015,0.239023846410982,0,0,23.6345238095238,71.6078870198875,STAT1
Ventricular Cardiac Muscle Cell Membrane Repolarization (GO:0099625),1/7,0.0483252883534015,0.239023846410982,0,0,23.6345238095238,71.6078870198875,KCNH2
Lymphocyte Apoptotic Process (GO:0070227),1/7,0.0483252883534015,0.239023846410982,0,0,23.6345238095238,71.6078870198875,TNFRSF21
Negative Regulation Of T-helper 17 Cell Differentiation (GO:2000320),1/7,0.0483252883534015,0.239023846410982,0,0,23.6345238095238,71.6078870198875,ZC3H12A
Blood Circulation (GO:0008015),2/50,0.0485159985807626,0.239023846410982,0,0,5.93854916067146,17.9692282675532,STAT1;MYOF
Cellular Response To Molecule Of Bacterial Origin (GO:0071219),3/117,0.0499264172751898,0.240780075291767,0,0,3.76525553012967,11.2852427463551,GFI1;ZC3H12A;GBP2
Amide Biosynthetic Process (GO:0043604),2/51,0.0502685398566633,0.240780075291767,0,0,5.81706063720452,17.3951976342059,CERS6;GLS2
Positive Regulation Of B Cell Activation (GO:0050871),2/52,0.0520436765381967,0.240780075291767,0,0,5.70043165467626,16.8486061128985,CD38;TNFSF13B
Negative Regulation Of Cell Population Proliferation (GO:0008285),6/379,0.0521201610658867,0.240780075291767,0,0,2.32183497170092,6.85917285224731,IFITM1;CDK6;EIF2AK2;IFI35;SOX7;IFIT3
Negative Regulation Of Cysteine-Type Endopeptidase Activity (GO:2000117),2/53,0.0538410080330441,0.240780075291767,0,0,5.58837635773734,16.3276702514051,LAMP3;IFI6
Regulation Of Helicase Activity (GO:0051095),1/8,0.0550369282195952,0.240780075291767,0,0,20.2571428571429,58.7406681681905,IFIT1
Regulation Of Interleukin-18 Production (GO:0032661),1/8,0.0550369282195952,0.240780075291767,0,0,20.2571428571429,58.7406681681905,GBP5
Regulation Of Lysosomal Protein Catabolic Process (GO:1905165),1/8,0.0550369282195952,0.240780075291767,0,0,20.2571428571429,58.7406681681905,MGAT3
Regulation Of Neutrophil Migration (GO:1902622),1/8,0.0550369282195952,0.240780075291767,0,0,20.2571428571429,58.7406681681905,JAM3
Regulation Of Pattern Recognition Receptor Signaling Pathway (GO:0062207),1/8,0.0550369282195952,0.240780075291767,0,0,20.2571428571429,58.7406681681905,GFI1
Regulation Of Protein Localization To Early Endosome (GO:1902965),1/8,0.0550369282195952,0.240780075291767,0,0,20.2571428571429,58.7406681681905,MGAT3
Positive Regulation Of Adaptive Immune Response (GO:0002821),1/8,0.0550369282195952,0.240780075291767,0,0,20.2571428571429,58.7406681681905,IL6ST
Positive Regulation Of Chromatin Binding (GO:0035563),1/8,0.0550369282195952,0.240780075291767,0,0,20.2571428571429,58.7406681681905,PARP9
Positive Regulation Of Fatty Acid Beta-Oxidation (GO:0032000),1/8,0.0550369282195952,0.240780075291767,0,0,20.2571428571429,58.7406681681905,IRS1
Synapse Pruning (GO:0098883),1/8,0.0550369282195952,0.240780075291767,0,0,20.2571428571429,58.7406681681905,ITGAM
Type B Pancreatic Cell Differentiation (GO:0003309),1/8,0.0550369282195952,0.240780075291767,0,0,20.2571428571429,58.7406681681905,CDK6
Positive Regulation Of Protein Localization To Early Endosome (GO:1902966),1/8,0.0550369282195952,0.240780075291767,0,0,20.2571428571429,58.7406681681905,MGAT3
Positive Regulation Of Protein Localization To Endosome (GO:1905668),1/8,0.0550369282195952,0.240780075291767,0,0,20.2571428571429,58.7406681681905,MGAT3
Intestinal Epithelial Cell Differentiation (GO:0060575),1/8,0.0550369282195952,0.240780075291767,0,0,20.2571428571429,58.7406681681905,IL6ST
Proteasome Assembly (GO:0043248),1/8,0.0550369282195952,0.240780075291767,0,0,20.2571428571429,58.7406681681905,NT5C3A
Protein poly-ADP-ribosylation (GO:0070212),1/8,0.0550369282195952,0.240780075291767,0,0,20.2571428571429,58.7406681681905,PARP9
Pyrimidine-Containing Compound Metabolic Process (GO:0072527),1/8,0.0550369282195952,0.240780075291767,0,0,20.2571428571429,58.7406681681905,NT5C3A
Modification-Dependent Macromolecule Catabolic Process (GO:0043632),1/8,0.0550369282195952,0.240780075291767,0,0,20.2571428571429,58.7406681681905,ISG15
Negative Regulation By Host Of Viral Genome Replication (GO:0044828),1/8,0.0550369282195952,0.240780075291767,0,0,20.2571428571429,58.7406681681905,ZC3H12A
Potassium Ion Transport (GO:0006813),3/122,0.0552693902901399,0.240780075291767,0,0,3.60613810741688,10.4417028721092,KCNH2;KCNC4;KCNN4
Regulation Of Cell Motility (GO:2000145),3/123,0.0563695923093405,0.240917744482513,0,0,3.57590579710145,10.2836807526377,CDK6;MGAT3;SGK3
Cellular Response To Lipopolysaccharide (GO:0071222),3/124,0.0574802149099807,0.240917744482513,0,0,3.54617319439454,10.1289858398821,GFI1;ZC3H12A;GBP2
Response To Peptide Hormone (GO:0043434),2/55,0.0575006752945871,0.240917744482513,0,0,5.37695126917334,15.3563501490445,IRS1;STAT1
Positive Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042531),2/55,0.0575006752945871,0.240917744482513,0,0,5.37695126917334,15.3563501490445,PARP9;IL6ST
Positive Regulation Of Interleukin-1 Beta Production (GO:0032731),2/57,0.0612444251750481,0.240917744482513,0,0,5.18090255068672,14.4696518154487,GBP5;AIM2
I-kappaB Phosphorylation (GO:0007252),1/9,0.0617015689907394,0.240917744482513,0,0,17.7241071428571,49.3695419098168,TLR7
NAD Biosynthesis Via Nicotinamide Riboside Salvage Pathway (GO:0034356),1/9,0.0617015689907394,0.240917744482513,0,0,17.7241071428571,49.3695419098168,PARP9
Negative Regulation Of Muscle Cell Apoptotic Process (GO:0010656),1/9,0.0617015689907394,0.240917744482513,0,0,17.7241071428571,49.3695419098168,ZC3H12A
Adherens Junction Assembly (GO:0034333),1/9,0.0617015689907394,0.240917744482513,0,0,17.7241071428571,49.3695419098168,JAM3
Regulation Of Mast Cell Activation (GO:0033003),1/9,0.0617015689907394,0.240917744482513,0,0,17.7241071428571,49.3695419098168,PLSCR1
Apical Protein Localization (GO:0045176),1/9,0.0617015689907394,0.240917744482513,0,0,17.7241071428571,49.3695419098168,JAM3
Nucleoside Metabolic Process (GO:0009116),1/9,0.0617015689907394,0.240917744482513,0,0,17.7241071428571,49.3695419098168,NT5C3A
Cell Differentiation Involved In Metanephros Development (GO:0072202),1/9,0.0617015689907394,0.240917744482513,0,0,17.7241071428571,49.3695419098168,STAT1
Dicarboxylic Acid Biosynthetic Process (GO:0043650),1/9,0.0617015689907394,0.240917744482513,0,0,17.7241071428571,49.3695419098168,GLS2
Ectoderm Development (GO:0007398),1/9,0.0617015689907394,0.240917744482513,0,0,17.7241071428571,49.3695419098168,ITGAM
Positive Regulation Of Mesenchymal Cell Proliferation (GO:0002053),1/9,0.0617015689907394,0.240917744482513,0,0,17.7241071428571,49.3695419098168,STAT1
Type II Interferon-Mediated Signaling Pathway (GO:0060333),1/9,0.0617015689907394,0.240917744482513,0,0,17.7241071428571,49.3695419098168,STAT1
Granulocyte Migration (GO:0097530),1/9,0.0617015689907394,0.240917744482513,0,0,17.7241071428571,49.3695419098168,JAM3
Positive Regulation Of Protein Kinase A Signaling (GO:0010739),1/9,0.0617015689907394,0.240917744482513,0,0,17.7241071428571,49.3695419098168,SPATC1L
Protein O-linked Glycosylation Via Threonine (GO:0018243),1/9,0.0617015689907394,0.240917744482513,0,0,17.7241071428571,49.3695419098168,GALNTL6
Protein Localization To Microtubule (GO:0035372),1/9,0.0617015689907394,0.240917744482513,0,0,17.7241071428571,49.3695419098168,MID2
Protein Localization To Microtubule Cytoskeleton (GO:0072698),1/9,0.0617015689907394,0.240917744482513,0,0,17.7241071428571,49.3695419098168,MID2
Regulation Of ER To Golgi Vesicle-Mediated Transport (GO:0060628),1/9,0.0617015689907394,0.240917744482513,0,0,17.7241071428571,49.3695419098168,PGAP1
Negative Regulation Of Cell Adhesion Mediated By Integrin (GO:0033629),1/9,0.0617015689907394,0.240917744482513,0,0,17.7241071428571,49.3695419098168,JAM3
Regulation Of Cellular Extravasation (GO:0002691),1/9,0.0617015689907394,0.240917744482513,0,0,17.7241071428571,49.3695419098168,JAM3
Positive Regulation Of Type II Interferon Production (GO:0032729),2/58,0.0631468761873393,0.244531730420931,0,0,5.08812949640288,14.0548988836829,TLR7;ISG15
Regulation Of Bone Mineralization (GO:0030500),2/58,0.0631468761873393,0.244531730420931,0,0,5.08812949640288,14.0548988836829,ANKH;ISG15
Regulation Of Type I Interferon Production (GO:0032479),2/59,0.0650692104833967,0.248218859231544,0,0,4.99861163700618,13.6577255649751,IRF7;XAF1
Regulation Of Chromatin Binding (GO:0035561),1/10,0.0683195372380126,0.248218859231544,0,0,15.7539682539683,42.2767112174724,PARP9
Negative Regulation Of Steroid Biosynthetic Process (GO:0010894),1/10,0.0683195372380126,0.248218859231544,0,0,15.7539682539683,42.2767112174724,GFI1
Regulation Of Mitochondrial Depolarization (GO:0051900),1/10,0.0683195372380126,0.248218859231544,0,0,15.7539682539683,42.2767112174724,IFI6
Cardiac Muscle Cell Membrane Repolarization (GO:0099622),1/10,0.0683195372380126,0.248218859231544,0,0,15.7539682539683,42.2767112174724,KCNH2
Endosomal Vesicle Fusion (GO:0034058),1/10,0.0683195372380126,0.248218859231544,0,0,15.7539682539683,42.2767112174724,SAMD9
Surfactant Homeostasis (GO:0043129),1/10,0.0683195372380126,0.248218859231544,0,0,15.7539682539683,42.2767112174724,OAS1
Positive Regulation Of Lipid Localization (GO:1905954),1/10,0.0683195372380126,0.248218859231544,0,0,15.7539682539683,42.2767112174724,ZC3H12A
Heparan Sulfate Proteoglycan Biosynthetic Process, Enzymatic Modification (GO:0015015),1/10,0.0683195372380126,0.248218859231544,0,0,15.7539682539683,42.2767112174724,HS3ST1
Insulin-Like Growth Factor Receptor Signaling Pathway (GO:0048009),1/10,0.0683195372380126,0.248218859231544,0,0,15.7539682539683,42.2767112174724,IRS1
Positive Regulation Of Toll-Like Receptor 4 Signaling Pathway (GO:0034145),1/10,0.0683195372380126,0.248218859231544,0,0,15.7539682539683,42.2767112174724,IFI35
Metanephric Mesenchyme Development (GO:0072075),1/10,0.0683195372380126,0.248218859231544,0,0,15.7539682539683,42.2767112174724,STAT1
miRNA Catabolic Process (GO:0010587),1/10,0.0683195372380126,0.248218859231544,0,0,15.7539682539683,42.2767112174724,ZC3H12A
Negative Regulation Of B Cell Proliferation (GO:0030889),1/10,0.0683195372380126,0.248218859231544,0,0,15.7539682539683,42.2767112174724,TNFRSF21
Regulation Of T-helper 2 Cell Cytokine Production (GO:2000551),1/10,0.0683195372380126,0.248218859231544,0,0,15.7539682539683,42.2767112174724,RSAD2
Negative Regulation Of T-helper Cell Differentiation (GO:0045623),1/10,0.0683195372380126,0.248218859231544,0,0,15.7539682539683,42.2767112174724,ZC3H12A
Phosphatidylinositol-Mediated Signaling (GO:0048015),2/62,0.0709518310122701,0.253752890183037,0,0,4.74796163069544,12.561938802111,PLCB3;IRS1
Glycerophospholipid Metabolic Process (GO:0006650),2/62,0.0709518310122701,0.253752890183037,0,0,4.74796163069544,12.561938802111,PLCB3;ABHD6
Potassium Ion Transmembrane Transport (GO:0071805),3/137,0.0728422497028221,0.253752890183037,0,0,3.20003244646334,8.382354237172,KCNH2;KCNC4;KCNN4
Negative Regulation Of Cellular Biosynthetic Process (GO:0031327),3/137,0.0728422497028221,0.253752890183037,0,0,3.20003244646334,8.382354237172,GFI1;ZC3H12A;EIF2AK2
G1/S Transition Of Mitotic Cell Cycle (GO:0000082),2/63,0.0729500370178326,0.253752890183037,0,0,4.66989031725439,12.2256817717039,CDK6;GFI1
Phosphatidylinositol Metabolic Process (GO:0046488),2/63,0.0729500370178326,0.253752890183037,0,0,4.66989031725439,12.2256817717039,PLCB3;PGAP1
Negative Regulation Of Heart Contraction (GO:0045822),1/11,0.0748911573283546,0.253752890183037,0,0,14.1778571428571,36.7450281891981,ZC3H12A
Negative Regulation Of Leukocyte Apoptotic Process (GO:2000107),1/11,0.0748911573283546,0.253752890183037,0,0,14.1778571428571,36.7450281891981,IRF7
Negative Regulation Of Potassium Ion Transmembrane Transport (GO:1901380),1/11,0.0748911573283546,0.253752890183037,0,0,14.1778571428571,36.7450281891981,KCNH2
Regulation Of Mesenchymal Cell Proliferation (GO:0010464),1/11,0.0748911573283546,0.253752890183037,0,0,14.1778571428571,36.7450281891981,STAT1
Regulation Of Type II Interferon-Mediated Signaling Pathway (GO:0060334),1/11,0.0748911573283546,0.253752890183037,0,0,14.1778571428571,36.7450281891981,PARP9
Glutamine Family Amino Acid Biosynthetic Process (GO:0009084),1/11,0.0748911573283546,0.253752890183037,0,0,14.1778571428571,36.7450281891981,GLS2
Positive Regulation Of Platelet Aggregation (GO:1901731),1/11,0.0748911573283546,0.253752890183037,0,0,14.1778571428571,36.7450281891981,IL6ST
Histone H2A Ubiquitination (GO:0033522),1/11,0.0748911573283546,0.253752890183037,0,0,14.1778571428571,36.7450281891981,BRCA2
Macrophage Activation Involved In Immune Response (GO:0002281),1/11,0.0748911573283546,0.253752890183037,0,0,14.1778571428571,36.7450281891981,IFI35
Regulation Of T-helper 17 Cell Differentiation (GO:2000319),1/11,0.0748911573283546,0.253752890183037,0,0,14.1778571428571,36.7450281891981,ZC3H12A
Regulation Of Cell Cycle Checkpoint (GO:1901976),1/11,0.0748911573283546,0.253752890183037,0,0,14.1778571428571,36.7450281891981,BRCA2
Positive Regulation Of Cysteine-Type Endopeptidase Activity (GO:2001056),2/64,0.0749663161220874,0.253752890183037,0,0,4.59433743327918,11.9026252652455,AIM2;SOX7
Positive Regulation Of Interleukin-1 Production (GO:0032732),2/64,0.0749663161220874,0.253752890183037,0,0,4.59433743327918,11.9026252652455,GBP5;AIM2
Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042509),2/65,0.0770003184643767,0.257291600367576,0,0,4.52118305355715,11.5920679450926,PARP9;IL6ST
Positive Regulation Of T Cell Proliferation (GO:0042102),2/65,0.0770003184643767,0.257291600367576,0,0,4.52118305355715,11.5920679450926,CD70;IL6ST
Cellular Response To Lipid (GO:0071396),4/228,0.0780399941408564,0.257291600367576,0,0,2.55930656934307,6.52759800770821,IRS1;GFI1;ZC3H12A;GBP2
Negative Regulation Of Intracellular Signal Transduction (GO:1902532),4/231,0.0809803157926107,0.257291600367576,0,0,2.52509727000868,6.3469561440398,AIM2;STAT1;ZC3H12A;IFI35
Extrinsic Apoptotic Signaling Pathway (GO:0097191),2/67,0.0811201132524592,0.257291600367576,0,0,4.38162700608744,11.0058773759683,IFI27;CD70
Regulation Of Chromosome Separation (GO:1905818),1/12,0.0814167514372148,0.257291600367576,0,0,12.8883116883117,32.3261313161532,PLSCR1
Regulation Of Hematopoietic Stem Cell Differentiation (GO:1902036),1/12,0.0814167514372148,0.257291600367576,0,0,12.8883116883117,32.3261313161532,EIF2AK2
Negative Regulation Of Potassium Ion Transport (GO:0043267),1/12,0.0814167514372148,0.257291600367576,0,0,12.8883116883117,32.3261313161532,KCNH2
Regulation Of Interleukin-5 Production (GO:0032674),1/12,0.0814167514372148,0.257291600367576,0,0,12.8883116883117,32.3261313161532,TNFRSF21
Negative Regulation Of Substrate Adhesion-Dependent Cell Spreading (GO:1900025),1/12,0.0814167514372148,0.257291600367576,0,0,12.8883116883117,32.3261313161532,GBP1
Axonal Transport Of Mitochondrion (GO:0019896),1/12,0.0814167514372148,0.257291600367576,0,0,12.8883116883117,32.3261313161532,SYBU
Positive Regulation Of Cellular Extravasation (GO:0002693),1/12,0.0814167514372148,0.257291600367576,0,0,12.8883116883117,32.3261313161532,JAM3
Positive Regulation Of Fatty Acid Oxidation (GO:0046321),1/12,0.0814167514372148,0.257291600367576,0,0,12.8883116883117,32.3261313161532,IRS1
Positive Regulation Of Insulin Receptor Signaling Pathway (GO:0046628),1/12,0.0814167514372148,0.257291600367576,0,0,12.8883116883117,32.3261313161532,IRS1
Positive Regulation Of mRNA Metabolic Process (GO:1903313),1/12,0.0814167514372148,0.257291600367576,0,0,12.8883116883117,32.3261313161532,ZC3H12A
Positive Regulation Of Myeloid Leukocyte Mediated Immunity (GO:0002888),1/12,0.0814167514372148,0.257291600367576,0,0,12.8883116883117,32.3261313161532,ITGAM
Histone Monoubiquitination (GO:0010390),1/12,0.0814167514372148,0.257291600367576,0,0,12.8883116883117,32.3261313161532,BRCA2
Negative Regulation By Host Of Viral Process (GO:0044793),1/12,0.0814167514372148,0.257291600367576,0,0,12.8883116883117,32.3261313161532,ZC3H12A
Negative Regulation Of Alcohol Biosynthetic Process (GO:1902931),1/12,0.0814167514372148,0.257291600367576,0,0,12.8883116883117,32.3261313161532,GFI1
Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043122),4/232,0.0819725527306275,0.257291600367576,0,0,2.51389422461263,6.28818163424943,TRAF4;STAT1;ZC3H12A;MID2
Positive Regulation Of Cellular Catabolic Process (GO:0031331),3/146,0.084438886425652,0.257291600367576,0,0,2.99726360595926,7.40841811184275,IRS1;ZC3H12A;MID2
Regulation Of Fatty Acid Beta-Oxidation (GO:0031998),1/13,0.0878966395118579,0.257291600367576,0,0,11.8136904761905,28.7260954045425,IRS1
Acute-Phase Response (GO:0006953),1/13,0.0878966395118579,0.257291600367576,0,0,11.8136904761905,28.7260954045425,PLSCR1
Negative Regulation Of Translational Initiation (GO:0045947),1/13,0.0878966395118579,0.257291600367576,0,0,11.8136904761905,28.7260954045425,EIF2AK2
Negative Regulation Of Viral Transcription (GO:0032897),1/13,0.0878966395118579,0.257291600367576,0,0,11.8136904761905,28.7260954045425,MID2
Cellular Response To Arsenic-Containing Substance (GO:0071243),1/13,0.0878966395118579,0.257291600367576,0,0,11.8136904761905,28.7260954045425,ZC3H12A
Positive Regulation Of T Cell Receptor Signaling Pathway (GO:0050862),1/13,0.0878966395118579,0.257291600367576,0,0,11.8136904761905,28.7260954045425,KCNN4
Response To Chemokine (GO:1990868),1/13,0.0878966395118579,0.257291600367576,0,0,11.8136904761905,28.7260954045425,ZC3H12A
Positive Regulation Of Cellular Response To Insulin Stimulus (GO:1900078),1/13,0.0878966395118579,0.257291600367576,0,0,11.8136904761905,28.7260954045425,IRS1
Positive Regulation Of Chromosome Separation (GO:1905820),1/13,0.0878966395118579,0.257291600367576,0,0,11.8136904761905,28.7260954045425,PLSCR1
Positive Regulation Of Glycogen Biosynthetic Process (GO:0045725),1/13,0.0878966395118579,0.257291600367576,0,0,11.8136904761905,28.7260954045425,IRS1
Suppression Of Viral Release By Host (GO:0044790),1/13,0.0878966395118579,0.257291600367576,0,0,11.8136904761905,28.7260954045425,MID2
Positive Regulation Of Leukocyte Degranulation (GO:0043302),1/13,0.0878966395118579,0.257291600367576,0,0,11.8136904761905,28.7260954045425,ITGAM
Glutamine Metabolic Process (GO:0006541),1/13,0.0878966395118579,0.257291600367576,0,0,11.8136904761905,28.7260954045425,GLS2
Heparan Sulfate Proteoglycan Metabolic Process (GO:0030201),1/13,0.0878966395118579,0.257291600367576,0,0,11.8136904761905,28.7260954045425,HS3ST1
Interleukin-6-Mediated Signaling Pathway (GO:0070102),1/13,0.0878966395118579,0.257291600367576,0,0,11.8136904761905,28.7260954045425,IL6ST
Positive Regulation Of Superoxide Anion Generation (GO:0032930),1/13,0.0878966395118579,0.257291600367576,0,0,11.8136904761905,28.7260954045425,ITGAM
Positive Regulation Of Type 2 Immune Response (GO:0002830),1/13,0.0878966395118579,0.257291600367576,0,0,11.8136904761905,28.7260954045425,RSAD2
Potassium Ion Export Across Plasma Membrane (GO:0097623),1/13,0.0878966395118579,0.257291600367576,0,0,11.8136904761905,28.7260954045425,KCNH2
Membrane Depolarization (GO:0051899),1/13,0.0878966395118579,0.257291600367576,0,0,11.8136904761905,28.7260954045425,KCNH2
Membrane Depolarization During Action Potential (GO:0086010),1/13,0.0878966395118579,0.257291600367576,0,0,11.8136904761905,28.7260954045425,KCNH2
Monoacylglycerol Metabolic Process (GO:0046462),1/13,0.0878966395118579,0.257291600367576,0,0,11.8136904761905,28.7260954045425,ABHD6
Negative Regulation Of DNA-binding Transcription Factor Activity (GO:0043433),3/149,0.0884699883629827,0.257291600367576,0,0,2.93522930315664,7.11820080486057,AIM2;GFI1;ZC3H12A
Negative Regulation Of Protein Binding (GO:0032091),2/71,0.0895574242014879,0.257291600367576,0,0,4.12678552809926,9.95741865561168,IFIT1;IFIT2
Positive Regulation Of Cell-Substrate Adhesion (GO:0010811),2/71,0.0895574242014879,0.257291600367576,0,0,4.12678552809926,9.95741865561168,CDK6;FBLN2
Negative Regulation Of Cellular Response To Growth Factor Stimulus (GO:0090288),2/71,0.0895574242014879,0.257291600367576,0,0,4.12678552809926,9.95741865561168,GPR155;SKIL
Regulation Of Inflammatory Response (GO:0050727),4/240,0.0901258713065576,0.257291600367576,0,0,2.42768773970061,5.84234711263614,AIM2;TLR7;IFI35;USP18
Plasma Membrane Organization (GO:0007009),2/72,0.0917060221212224,0.257291600367576,0,0,4.06762589928058,9.7182385020084,PLSCR1;MYOF
Positive Regulation Of Protein Localization To Nucleus (GO:1900182),2/72,0.0917060221212224,0.257291600367576,0,0,4.06762589928058,9.7182385020084,ZC3H12A;PARP9
Positive Regulation Of NF-kappaB Transcription Factor Activity (GO:0051092),3/152,0.0925809380308074,0.257291600367576,0,0,2.87569302597024,6.8432062070485,AIM2;EIF2AK2;MID2
L-glutamate Transmembrane Transport (GO:0015813),1/14,0.0943311393483675,0.257291600367576,0,0,10.9043956043956,25.7446665914561,SLC7A11
RNA Phosphodiester Bond Hydrolysis, Endonucleolytic (GO:0090502),1/14,0.0943311393483675,0.257291600367576,0,0,10.9043956043956,25.7446665914561,ZC3H12A
Regulation Of Integrin Activation (GO:0033623),1/14,0.0943311393483675,0.257291600367576,0,0,10.9043956043956,25.7446665914561,JAM3
Regulation Of Leukocyte Activation (GO:0002694),1/14,0.0943311393483675,0.257291600367576,0,0,10.9043956043956,25.7446665914561,PLSCR1
Cellular Response To Exogenous dsRNA (GO:0071360),1/14,0.0943311393483675,0.257291600367576,0,0,10.9043956043956,25.7446665914561,IFIT1
Regulation Of Superoxide Anion Generation (GO:0032928),1/14,0.0943311393483675,0.257291600367576,0,0,10.9043956043956,25.7446665914561,ITGAM
Photoreceptor Cell Development (GO:0042461),1/14,0.0943311393483675,0.257291600367576,0,0,10.9043956043956,25.7446665914561,CFAP418
Positive Regulation Of Acute Inflammatory Response (GO:0002675),1/14,0.0943311393483675,0.257291600367576,0,0,10.9043956043956,25.7446665914561,IL6ST
Endoderm Development (GO:0007492),1/14,0.0943311393483675,0.257291600367576,0,0,10.9043956043956,25.7446665914561,SOX7
Positive Regulation Of Glycogen Metabolic Process (GO:0070875),1/14,0.0943311393483675,0.257291600367576,0,0,10.9043956043956,25.7446665914561,IRS1
Establishment Of Protein Localization To Chromosome (GO:0070199),1/14,0.0943311393483675,0.257291600367576,0,0,10.9043956043956,25.7446665914561,BRCA2
Glucosamine-Containing Compound Metabolic Process (GO:1901071),1/14,0.0943311393483675,0.257291600367576,0,0,10.9043956043956,25.7446665914561,MGAT3
Vascular Endothelial Growth Factor Signaling Pathway (GO:0038084),1/14,0.0943311393483675,0.257291600367576,0,0,10.9043956043956,25.7446665914561,GAB1
Histone H2A Monoubiquitination (GO:0035518),1/14,0.0943311393483675,0.257291600367576,0,0,10.9043956043956,25.7446665914561,BRCA2
Membrane Repolarization During Cardiac Muscle Cell Action Potential (GO:0086013),1/14,0.0943311393483675,0.257291600367576,0,0,10.9043956043956,25.7446665914561,KCNH2
Protein Localization To Vacuole (GO:0072665),1/14,0.0943311393483675,0.257291600367576,0,0,10.9043956043956,25.7446665914561,GBP1
Mitochondrion Transport Along Microtubule (GO:0047497),1/14,0.0943311393483675,0.257291600367576,0,0,10.9043956043956,25.7446665914561,SYBU
Positive Regulation Of Programmed Cell Death (GO:0043068),4/245,0.0954129101701629,0.257549057445046,0,0,2.37671502559288,5.58419030811539,GBP5;GBP2;GBP1;IFIT2
Regulation Of BMP Signaling Pathway (GO:0030510),2/75,0.0982409429805646,0.257549057445046,0,0,3.89987188331527,9.04899836868379,GPR155;SKIL
Positive Regulation Of Nucleic Acid-Templated Transcription (GO:1903508),7/557,0.0995023994531051,0.257549057445046,0,0,1.83396200814111,4.2320021666757,KCNH2;STAT1;MYB;IRF7;CD38;BRCA2;PARP9
3'-UTR-mediated mRNA Destabilization (GO:0061158),1/15,0.100720566567244,0.257549057445046,0,0,10.125,23.2409782989179,ZC3H12A
Regulation Of Cellular Response To Heat (GO:1900034),1/15,0.100720566567244,0.257549057445046,0,0,10.125,23.2409782989179,IER5
B Cell Mediated Immunity (GO:0019724),1/15,0.100720566567244,0.257549057445046,0,0,10.125,23.2409782989179,CD70
Negative Regulation Of Macrophage Activation (GO:0043031),1/15,0.100720566567244,0.257549057445046,0,0,10.125,23.2409782989179,ZC3H12A
L-glutamate Import (GO:0051938),1/15,0.100720566567244,0.257549057445046,0,0,10.125,23.2409782989179,SLC7A11
N-acetylglucosamine Metabolic Process (GO:0006044),1/15,0.100720566567244,0.257549057445046,0,0,10.125,23.2409782989179,MGAT3
Negative Regulation Of Phagocytosis (GO:0050765),1/15,0.100720566567244,0.257549057445046,0,0,10.125,23.2409782989179,PLSCR1
Regulation Of Interleukin-13 Production (GO:0032656),1/15,0.100720566567244,0.257549057445046,0,0,10.125,23.2409782989179,TNFRSF21
Alpha-Beta T Cell Activation (GO:0046631),1/15,0.100720566567244,0.257549057445046,0,0,10.125,23.2409782989179,RSAD2
Amyloid-Beta Metabolic Process (GO:0050435),1/15,0.100720566567244,0.257549057445046,0,0,10.125,23.2409782989179,MGAT3
Astrocyte Development (GO:0014002),1/15,0.100720566567244,0.257549057445046,0,0,10.125,23.2409782989179,CDK6
Regulation Of Systemic Arterial Blood Pressure (GO:0003073),1/15,0.100720566567244,0.257549057445046,0,0,10.125,23.2409782989179,PLCB3
Retrograde Axonal Transport (GO:0008090),1/15,0.100720566567244,0.257549057445046,0,0,10.125,23.2409782989179,KIF1C
Positive Regulation Of Glucose Metabolic Process (GO:0010907),1/15,0.100720566567244,0.257549057445046,0,0,10.125,23.2409782989179,IRS1
Stem Cell Development (GO:0048864),1/15,0.100720566567244,0.257549057445046,0,0,10.125,23.2409782989179,TAPT1
Glutamine Family Amino Acid Catabolic Process (GO:0009065),1/15,0.100720566567244,0.257549057445046,0,0,10.125,23.2409782989179,GLS2
Protein Localization To Chromosome, Telomeric Region (GO:0070198),1/15,0.100720566567244,0.257549057445046,0,0,10.125,23.2409782989179,BRCA2
Membrane Repolarization During Action Potential (GO:0086011),1/15,0.100720566567244,0.257549057445046,0,0,10.125,23.2409782989179,KCNH2
miRNA Metabolic Process (GO:0010586),1/15,0.100720566567244,0.257549057445046,0,0,10.125,23.2409782989179,ZC3H12A
Negative Regulation Of Cation Transmembrane Transport (GO:1904063),1/15,0.100720566567244,0.257549057445046,0,0,10.125,23.2409782989179,KCNH2
Response To Lipopolysaccharide (GO:0032496),3/159,0.102473468502424,0.259660787977864,0,0,2.74568004459309,6.25507472164206,GFI1;ZC3H12A;GBP2
Cell Morphogenesis Involved In Neuron Differentiation (GO:0048667),2/77,0.102668720328419,0.259660787977864,0,0,3.79549160671463,8.63947935016108,CFAP418;BTBD3
Positive Regulation Of JNK Cascade (GO:0046330),2/77,0.102668720328419,0.259660787977864,0,0,3.79549160671463,8.63947935016108,TRAF4;WNT16
Positive Regulation Of Response To Stimulus (GO:0048584),2/77,0.102668720328419,0.259660787977864,0,0,3.79549160671463,8.63947935016108,RSAD2;IER5
Negative Regulation Of Interleukin-10 Production (GO:0032693),1/16,0.107065234575357,0.259660787977864,0,0,9.44952380952381,21.1132313244344,TNFRSF21
Negative Regulation Of Viral-Induced Cytoplasmic Pattern Recognition Receptor Signaling Pathway (GO:0039532),1/16,0.107065234575357,0.259660787977864,0,0,9.44952380952381,21.1132313244344,LILRA4
Regulation Of Osteoblast Proliferation (GO:0033688),1/16,0.107065234575357,0.259660787977864,0,0,9.44952380952381,21.1132313244344,EIF2AK2
Regulation Of Protein Kinase A Signaling (GO:0010738),1/16,0.107065234575357,0.259660787977864,0,0,9.44952380952381,21.1132313244344,SPATC1L
Cell Surface Toll-Like Receptor Signaling Pathway (GO:0140895),1/16,0.107065234575357,0.259660787977864,0,0,9.44952380952381,21.1132313244344,OAS1
Regulation Of Response To Cytokine Stimulus (GO:0060759),1/16,0.107065234575357,0.259660787977864,0,0,9.44952380952381,21.1132313244344,PARP9
Regulation Of Secretion (GO:0051046),1/16,0.107065234575357,0.259660787977864,0,0,9.44952380952381,21.1132313244344,OAS2
Regulation Of Stem Cell Proliferation (GO:0072091),1/16,0.107065234575357,0.259660787977864,0,0,9.44952380952381,21.1132313244344,EIF2AK2
Stabilization Of Membrane Potential (GO:0030322),1/16,0.107065234575357,0.259660787977864,0,0,9.44952380952381,21.1132313244344,KCNN4
Positive Regulation Of Homotypic Cell-Cell Adhesion (GO:0034112),1/16,0.107065234575357,0.259660787977864,0,0,9.44952380952381,21.1132313244344,IL6ST
Establishment Of Protein Localization To Endoplasmic Reticulum (GO:0072599),1/16,0.107065234575357,0.259660787977864,0,0,9.44952380952381,21.1132313244344,MAN1A1
Positive Regulation Of Muscle Hypertrophy (GO:0014742),1/16,0.107065234575357,0.259660787977864,0,0,9.44952380952381,21.1132313244344,IL6ST
Lymphocyte Mediated Immunity (GO:0002449),1/16,0.107065234575357,0.259660787977864,0,0,9.44952380952381,21.1132313244344,CD70
Protein Alpha-1,2-Demannosylation (GO:0036508),1/16,0.107065234575357,0.259660787977864,0,0,9.44952380952381,21.1132313244344,MAN1A1
Protein Localization To Mitochondrion (GO:0070585),1/16,0.107065234575357,0.259660787977864,0,0,9.44952380952381,21.1132313244344,ISG15
Negative Regulation Of ATP-dependent Activity (GO:0032780),1/16,0.107065234575357,0.259660787977864,0,0,9.44952380952381,21.1132313244344,IFIT1
Negative Regulation Of Insulin Secretion (GO:0046676),1/17,0.113365454665336,0.266027164189729,0,0,8.85848214285714,19.2861431154535,IRS1
Negative Regulation Of Leukocyte Activation (GO:0002695),1/17,0.113365454665336,0.266027164189729,0,0,8.85848214285714,19.2861431154535,ZC3H12A
NAD Biosynthetic Process (GO:0009435),1/17,0.113365454665336,0.266027164189729,0,0,8.85848214285714,19.2861431154535,PARP9
Carboxylic Acid Biosynthetic Process (GO:0046394),1/17,0.113365454665336,0.266027164189729,0,0,8.85848214285714,19.2861431154535,CARNS1
Cellular Response To dsRNA (GO:0071359),1/17,0.113365454665336,0.266027164189729,0,0,8.85848214285714,19.2861431154535,IFIT1
Regulation Of Viral Transcription (GO:0046782),1/17,0.113365454665336,0.266027164189729,0,0,8.85848214285714,19.2861431154535,MID2
Positive Regulation Of Cardiac Muscle Hypertrophy (GO:0010613),1/17,0.113365454665336,0.266027164189729,0,0,8.85848214285714,19.2861431154535,IL6ST
Positive Regulation Of Cartilage Development (GO:0061036),1/17,0.113365454665336,0.266027164189729,0,0,8.85848214285714,19.2861431154535,TAPT1
Toll-Like Receptor 4 Signaling Pathway (GO:0034142),1/17,0.113365454665336,0.266027164189729,0,0,8.85848214285714,19.2861431154535,OAS1
Ventricular Cardiac Muscle Cell Action Potential (GO:0086005),1/17,0.113365454665336,0.266027164189729,0,0,8.85848214285714,19.2861431154535,KCNH2
Myeloid Cell Activation Involved In Immune Response (GO:0002275),1/17,0.113365454665336,0.266027164189729,0,0,8.85848214285714,19.2861431154535,IFI35
Regulation Of Cartilage Development (GO:0061035),1/17,0.113365454665336,0.266027164189729,0,0,8.85848214285714,19.2861431154535,TAPT1
Negative Regulation Of Cellular Senescence (GO:2000773),1/17,0.113365454665336,0.266027164189729,0,0,8.85848214285714,19.2861431154535,CDK6
Regulation Of Defense Response To Virus (GO:0050688),1/18,0.119621535957102,0.270586214749118,0,0,8.33697478991597,17.7029189099684,HERC5
Negative Regulation Of Peptide Hormone Secretion (GO:0090278),1/18,0.119621535957102,0.270586214749118,0,0,8.33697478991597,17.7029189099684,IRS1
T-helper Cell Differentiation (GO:0042093),1/18,0.119621535957102,0.270586214749118,0,0,8.33697478991597,17.7029189099684,MYB
Neural Crest Cell Differentiation (GO:0014033),1/18,0.119621535957102,0.270586214749118,0,0,8.33697478991597,17.7029189099684,TAPT1
Regulation Of Oligodendrocyte Differentiation (GO:0048713),1/18,0.119621535957102,0.270586214749118,0,0,8.33697478991597,17.7029189099684,TNFRSF21
Regulation Of Ventricular Cardiac Muscle Cell Membrane Repolarization (GO:0060307),1/18,0.119621535957102,0.270586214749118,0,0,8.33697478991597,17.7029189099684,KCNH2
Positive Regulation Of NLRP3 Inflammasome Complex Assembly (GO:1900227),1/18,0.119621535957102,0.270586214749118,0,0,8.33697478991597,17.7029189099684,GBP5
Positive Regulation Of Cytokine Production Involved In Inflammatory Response (GO:1900017),1/18,0.119621535957102,0.270586214749118,0,0,8.33697478991597,17.7029189099684,GBP5
Glycerolipid Catabolic Process (GO:0046503),1/18,0.119621535957102,0.270586214749118,0,0,8.33697478991597,17.7029189099684,ABHD6
Positive Regulation Of Neuroblast Proliferation (GO:0002052),1/18,0.119621535957102,0.270586214749118,0,0,8.33697478991597,17.7029189099684,HAPLN3
Positive Regulation Of Stress-Activated Protein Kinase Signaling Cascade (GO:0070304),1/18,0.119621535957102,0.270586214749118,0,0,8.33697478991597,17.7029189099684,EIF2AK2
Membrane Repolarization (GO:0086009),1/18,0.119621535957102,0.270586214749118,0,0,8.33697478991597,17.7029189099684,KCNH2
Regulation Of DNA Damage Checkpoint (GO:2000001),1/18,0.119621535957102,0.270586214749118,0,0,8.33697478991597,17.7029189099684,BRCA2
Negative Regulation Of T Cell Receptor Signaling Pathway (GO:0050860),1/18,0.119621535957102,0.270586214749118,0,0,8.33697478991597,17.7029189099684,GBP1
Regulation Of Cell Cycle G2/M Phase Transition (GO:1902749),1/18,0.119621535957102,0.270586214749118,0,0,8.33697478991597,17.7029189099684,CDK6
Defense Response To Gram-positive Bacterium (GO:0050830),2/85,0.120897390580283,0.272163742909201,0,0,3.42827424807142,7.24330275846148,GBP2;GBP4
Integrin-Mediated Signaling Pathway (GO:0007229),2/85,0.120897390580283,0.272163742909201,0,0,3.42827424807142,7.24330275846148,ITGAM;ISG15
Negative Regulation Of Binding (GO:0051100),2/86,0.123229472562875,0.275756526973044,0,0,3.38729016786571,7.09199324098714,IFIT1;IFIT2
Glucose Homeostasis (GO:0042593),2/87,0.125572521374024,0.275756526973044,0,0,3.34727041895895,6.94515709216845,OAS1;IRS1
N-glycan Processing (GO:0006491),1/19,0.125833785491345,0.275756526973044,0,0,7.8734126984127,16.319957921301,MAN1A1
Regulation Of Granulocyte Chemotaxis (GO:0071622),1/19,0.125833785491345,0.275756526973044,0,0,7.8734126984127,16.319957921301,JAM3
Regulation Of Megakaryocyte Differentiation (GO:0045652),1/19,0.125833785491345,0.275756526973044,0,0,7.8734126984127,16.319957921301,MYB
Neuron Apoptotic Process (GO:0051402),1/19,0.125833785491345,0.275756526973044,0,0,7.8734126984127,16.319957921301,TNFRSF21
Regulation Of Transcription Involved In G1/S Transition Of Mitotic Cell Cycle (GO:0000083),1/19,0.125833785491345,0.275756526973044,0,0,7.8734126984127,16.319957921301,GFI1
Release Of Cytochrome C From Mitochondria (GO:0001836),1/19,0.125833785491345,0.275756526973044,0,0,7.8734126984127,16.319957921301,IFI6
Response To Fatty Acid (GO:0070542),1/19,0.125833785491345,0.275756526973044,0,0,7.8734126984127,16.319957921301,IRS1
Regulation Of Acute Inflammatory Response (GO:0002673),1/19,0.125833785491345,0.275756526973044,0,0,7.8734126984127,16.319957921301,IL6ST
Regulation Of Behavior (GO:0050795),1/19,0.125833785491345,0.275756526973044,0,0,7.8734126984127,16.319957921301,AIM2
Negative Regulation Of Apoptotic Process (GO:0043066),6/482,0.126009890115206,0.275756526973044,0,0,1.80980392156863,3.74881858080194,LAMP3;ZC3H12A;IFI6;CD38;IL6ST;IFIT3
Cellular Response To Chemical Stress (GO:0062197),2/89,0.13029045250079,0.280393589499188,0,0,3.26999090382866,6.66420572344015,ZC3H12A;MGAT3
T Cell Mediated Immunity (GO:0002456),1/20,0.132002508127673,0.280393589499188,0,0,7.45864661654135,15.1032697801819,CD70
Negative Regulation Of Protein Localization To Cell Periphery (GO:1904376),1/20,0.132002508127673,0.280393589499188,0,0,7.45864661654135,15.1032697801819,GBP1
Negative Regulation Of Protein Localization To Plasma Membrane (GO:1903077),1/20,0.132002508127673,0.280393589499188,0,0,7.45864661654135,15.1032697801819,GBP1
Regulation Of Protein Localization To Cell Periphery (GO:1904375),1/20,0.132002508127673,0.280393589499188,0,0,7.45864661654135,15.1032697801819,GBP1
Phosphatidylserine Metabolic Process (GO:0006658),1/20,0.132002508127673,0.280393589499188,0,0,7.45864661654135,15.1032697801819,PLSCR1
Positive Regulation Of Antigen Receptor-Mediated Signaling Pathway (GO:0050857),1/20,0.132002508127673,0.280393589499188,0,0,7.45864661654135,15.1032697801819,KCNN4
Positive Regulation Of Lipid Catabolic Process (GO:0050996),1/20,0.132002508127673,0.280393589499188,0,0,7.45864661654135,15.1032697801819,IRS1
Positive Regulation Of Lipid Storage (GO:0010884),1/20,0.132002508127673,0.280393589499188,0,0,7.45864661654135,15.1032697801819,ZC3H12A
Glutamate Metabolic Process (GO:0006536),1/20,0.132002508127673,0.280393589499188,0,0,7.45864661654135,15.1032697801819,GLS2
Microglial Cell Activation (GO:0001774),1/20,0.132002508127673,0.280393589499188,0,0,7.45864661654135,15.1032697801819,ITGAM
Negative Regulation Of B Cell Activation (GO:0050869),1/20,0.132002508127673,0.280393589499188,0,0,7.45864661654135,15.1032697801819,TNFRSF21
Negative Regulation Of Cytokine Production Involved In Inflammatory Response (GO:1900016),1/20,0.132002508127673,0.280393589499188,0,0,7.45864661654135,15.1032697801819,ZC3H12A
Negative Regulation Of Programmed Cell Death (GO:0043069),5/381,0.132445842723659,0.280701662168835,0,0,1.90501799123905,3.85114903542736,IFI6;CD38;SLC7A11;IL6ST;IFIT3
Negative Regulation Of Interleukin-2 Production (GO:0032703),1/21,0.138128006669989,0.288200563805897,0,0,7.08535714285714,14.0259918926067,GBP1
Regulation Of Lipid Storage (GO:0010883),1/21,0.138128006669989,0.288200563805897,0,0,7.08535714285714,14.0259918926067,ZC3H12A
Aminoglycan Biosynthetic Process (GO:0006023),1/21,0.138128006669989,0.288200563805897,0,0,7.08535714285714,14.0259918926067,HS3ST1
Regulation Of Neurotransmitter Transport (GO:0051588),1/21,0.138128006669989,0.288200563805897,0,0,7.08535714285714,14.0259918926067,MYOF
Plasma Membrane Repair (GO:0001778),1/21,0.138128006669989,0.288200563805897,0,0,7.08535714285714,14.0259918926067,MYOF
Positive Regulation Of G2/M Transition Of Mitotic Cell Cycle (GO:0010971),1/21,0.138128006669989,0.288200563805897,0,0,7.08535714285714,14.0259918926067,TNFSF13B
Positive Regulation Of T Cell Cytokine Production (GO:0002726),1/21,0.138128006669989,0.288200563805897,0,0,7.08535714285714,14.0259918926067,RSAD2
Negative Regulation Of Extrinsic Apoptotic Signaling Pathway In Absence Of Ligand (GO:2001240),1/22,0.144210581850911,0.294364766858368,0,0,6.74761904761905,13.0666338789949,IFI6
Fc-epsilon Receptor Signaling Pathway (GO:0038095),1/22,0.144210581850911,0.294364766858368,0,0,6.74761904761905,13.0666338789949,LILRA4
Negative Regulation Of Signal Transduction In Absence Of Ligand (GO:1901099),1/22,0.144210581850911,0.294364766858368,0,0,6.74761904761905,13.0666338789949,IFI6
Regulation Of Protein Export From Nucleus (GO:0046825),1/22,0.144210581850911,0.294364766858368,0,0,6.74761904761905,13.0666338789949,IFI27
Cytoskeleton-Dependent Intracellular Transport (GO:0030705),1/22,0.144210581850911,0.294364766858368,0,0,6.74761904761905,13.0666338789949,KIF1C
Positive Regulation Of Cilium Assembly (GO:0045724),1/22,0.144210581850911,0.294364766858368,0,0,6.74761904761905,13.0666338789949,TAPT1
Vesicle Transport Along Microtubule (GO:0047496),1/22,0.144210581850911,0.294364766858368,0,0,6.74761904761905,13.0666338789949,KIF1C
Postreplication Repair (GO:0006301),1/22,0.144210581850911,0.294364766858368,0,0,6.74761904761905,13.0666338789949,TNFSF13B
Modulation By Host Of Viral Process (GO:0044788),1/22,0.144210581850911,0.294364766858368,0,0,6.74761904761905,13.0666338789949,IFI27
Regulation Of Cardiac Muscle Cell Membrane Repolarization (GO:0099623),1/22,0.144210581850911,0.294364766858368,0,0,6.74761904761905,13.0666338789949,KCNH2
Regulation Of Defense Response (GO:0031347),2/97,0.149548873463322,0.298282174778024,0,0,2.99341158652026,5.68787722487429,HERC5;USP18
Adaptive Immune Response Based On Somatic Recombination Of Immune Receptors Built From Immunoglobulin Superfamily Domains (GO:0002460),1/23,0.150250532247379,0.298282174778024,0,0,6.44058441558442,12.2078132219577,CD70
Cellular Response To Interleukin-6 (GO:0071354),1/23,0.150250532247379,0.298282174778024,0,0,6.44058441558442,12.2078132219577,IL6ST
Regulation Of Toll-Like Receptor 4 Signaling Pathway (GO:0034143),1/23,0.150250532247379,0.298282174778024,0,0,6.44058441558442,12.2078132219577,IFI35
Glial Cell Development (GO:0021782),1/23,0.150250532247379,0.298282174778024,0,0,6.44058441558442,12.2078132219577,CDK6
Translesion Synthesis (GO:0019985),1/23,0.150250532247379,0.298282174778024,0,0,6.44058441558442,12.2078132219577,TNFSF13B
Positive Regulation Of Neuron Apoptotic Process (GO:0043525),1/23,0.150250532247379,0.298282174778024,0,0,6.44058441558442,12.2078132219577,ITGAM
Heparan Sulfate Proteoglycan Biosynthetic Process (GO:0015012),1/23,0.150250532247379,0.298282174778024,0,0,6.44058441558442,12.2078132219577,HS3ST1
Positive Regulation Of Protein Targeting To Membrane (GO:0090314),1/23,0.150250532247379,0.298282174778024,0,0,6.44058441558442,12.2078132219577,ITGAM
Potassium Ion Homeostasis (GO:0055075),1/23,0.150250532247379,0.298282174778024,0,0,6.44058441558442,12.2078132219577,KCNH2
Protein Localization To Cell Junction (GO:1902414),1/23,0.150250532247379,0.298282174778024,0,0,6.44058441558442,12.2078132219577,JAM3
Protein Targeting To ER (GO:0045047),1/23,0.150250532247379,0.298282174778024,0,0,6.44058441558442,12.2078132219577,MAN1A1
Regulation Of Cardiac Muscle Hypertrophy (GO:0010611),1/23,0.150250532247379,0.298282174778024,0,0,6.44058441558442,12.2078132219577,IL6ST
Cellular Response To Insulin Stimulus (GO:0032869),2/99,0.154450252361154,0.303779986228873,0,0,2.93139509011348,5.47550371667707,IRS1;GAB1
Regulation Of Cell Differentiation (GO:0045595),3/193,0.155786194752736,0.303779986228873,0,0,2.25045766590389,4.18421013088844,CDK6;PLEKHB1;EIF2AK2
Regulation Of Execution Phase Of Apoptosis (GO:1900117),1/24,0.156248154447157,0.303779986228873,0,0,6.16024844720497,11.4353295751391,ZC3H12A
Acylglycerol Catabolic Process (GO:0046464),1/24,0.156248154447157,0.303779986228873,0,0,6.16024844720497,11.4353295751391,ABHD6
Regulation Of Neuroblast Proliferation (GO:1902692),1/24,0.156248154447157,0.303779986228873,0,0,6.16024844720497,11.4353295751391,HAPLN3
Regulation Of Viral Life Cycle (GO:1903900),1/24,0.156248154447157,0.303779986228873,0,0,6.16024844720497,11.4353295751391,LAMP3
Positive Regulation Of Cell Cycle G2/M Phase Transition (GO:1902751),1/24,0.156248154447157,0.303779986228873,0,0,6.16024844720497,11.4353295751391,TNFSF13B
Positive Regulation Of p38MAPK Cascade (GO:1900745),1/24,0.156248154447157,0.303779986228873,0,0,6.16024844720497,11.4353295751391,ZC3H12A
Positive Regulation Of Vascular Endothelial Growth Factor Production (GO:0010575),1/24,0.156248154447157,0.303779986228873,0,0,6.16024844720497,11.4353295751391,IL6ST
Negative Regulation Of Antigen Receptor-Mediated Signaling Pathway (GO:0050858),1/24,0.156248154447157,0.303779986228873,0,0,6.16024844720497,11.4353295751391,GBP1
Cellular Response To Oxygen-Containing Compound (GO:1901701),5/406,0.159617461838157,0.308350953790565,0,0,1.78395921959806,3.27352090782316,IRS1;GFI1;ZC3H12A;AGAP3;GBP2
Activation Of GTPase Activity (GO:0090630),2/102,0.161859715665696,0.308350953790565,0,0,2.84302158273381,5.17721414981775,SGSM1;AGAP3
Regulation Of Glycogen Biosynthetic Process (GO:0005979),1/25,0.162203742961031,0.308350953790565,0,0,5.90327380952381,10.7374769009065,IRS1
Negative Regulation Of Protein Localization To Membrane (GO:1905476),1/25,0.162203742961031,0.308350953790565,0,0,5.90327380952381,10.7374769009065,GBP1
Negative Regulation Of Protein Transport (GO:0051224),1/25,0.162203742961031,0.308350953790565,0,0,5.90327380952381,10.7374769009065,RSAD2
Negative Regulation Of Proteolysis Involved In Protein Catabolic Process (GO:1903051),1/25,0.162203742961031,0.308350953790565,0,0,5.90327380952381,10.7374769009065,LAMP3
Regulation Of Myelination (GO:0031641),1/25,0.162203742961031,0.308350953790565,0,0,5.90327380952381,10.7374769009065,TNFRSF21
Regulation Of Neutrophil Chemotaxis (GO:0090022),1/25,0.162203742961031,0.308350953790565,0,0,5.90327380952381,10.7374769009065,JAM3
Regulation Of Platelet Aggregation (GO:0090330),1/25,0.162203742961031,0.308350953790565,0,0,5.90327380952381,10.7374769009065,IL6ST
Positive Regulation Of Glucose Import (GO:0046326),1/25,0.162203742961031,0.308350953790565,0,0,5.90327380952381,10.7374769009065,IRS1
Regulation Of Biomineral Tissue Development (GO:0070167),1/25,0.162203742961031,0.308350953790565,0,0,5.90327380952381,10.7374769009065,ANKH
Positive Regulation Of Vasculature Development (GO:1904018),2/104,0.166834986880132,0.31080285357595,0,0,2.78699393426435,4.99080954824414,ZC3H12A;GAB1
Positive Regulation Of Intracellular Signal Transduction (GO:1902533),6/525,0.16692533550531,0.31080285357595,0,0,1.65617640762149,2.96490134629168,EIF2AK2;SPATC1L;TLR7;IFI35;WNT16;MID2
Negative Regulation Of Insulin Receptor Signaling Pathway (GO:0046627),1/26,0.168117590297724,0.31080285357595,0,0,5.66685714285714,10.1045253821588,IRS1
Negative Regulation Of Interleukin-1 Beta Production (GO:0032691),1/26,0.168117590297724,0.31080285357595,0,0,5.66685714285714,10.1045253821588,ZC3H12A
Fc Receptor Signaling Pathway (GO:0038093),1/26,0.168117590297724,0.31080285357595,0,0,5.66685714285714,10.1045253821588,LILRA4
L-amino Acid Transport (GO:0015807),1/26,0.168117590297724,0.31080285357595,0,0,5.66685714285714,10.1045253821588,SLC7A11
Acute Inflammatory Response (GO:0002526),1/26,0.168117590297724,0.31080285357595,0,0,5.66685714285714,10.1045253821588,PLSCR1
Regulation Of Myeloid Cell Differentiation (GO:0045637),1/26,0.168117590297724,0.31080285357595,0,0,5.66685714285714,10.1045253821588,CDK6
Nucleic Acid Phosphodiester Bond Hydrolysis (GO:0090305),1/26,0.168117590297724,0.31080285357595,0,0,5.66685714285714,10.1045253821588,ZC3H12A
Plasma Membrane Invagination (GO:0099024),1/26,0.168117590297724,0.31080285357595,0,0,5.66685714285714,10.1045253821588,ITGAM
Regulation Of Vascular Endothelial Growth Factor Production (GO:0010574),1/26,0.168117590297724,0.31080285357595,0,0,5.66685714285714,10.1045253821588,IL6ST
Positive Regulation Of Erythrocyte Differentiation (GO:0045648),1/26,0.168117590297724,0.31080285357595,0,0,5.66685714285714,10.1045253821588,STAT1
Positive Regulation Of Phosphatidylinositol 3-Kinase Activity (GO:0043552),1/26,0.168117590297724,0.31080285357595,0,0,5.66685714285714,10.1045253821588,IRS1
Protein Localization To Cell Surface (GO:0034394),1/26,0.168117590297724,0.31080285357595,0,0,5.66685714285714,10.1045253821588,JAM3
DNA Synthesis Involved In DNA Repair (GO:0000731),1/27,0.173989986902528,0.316108840265129,0,0,5.44862637362637,9.52832638792415,TNFSF13B
GPI Anchor Metabolic Process (GO:0006505),1/27,0.173989986902528,0.316108840265129,0,0,5.44862637362637,9.52832638792415,PGAP1
Regulation Of Extrinsic Apoptotic Signaling Pathway In Absence Of Ligand (GO:2001239),1/27,0.173989986902528,0.316108840265129,0,0,5.44862637362637,9.52832638792415,IFI6
Cell Surface Receptor Signaling Pathway Involved In Cell-Cell Signaling (GO:1905114),1/27,0.173989986902528,0.316108840265129,0,0,5.44862637362637,9.52832638792415,ITGAM
Positive Regulation Of Cytosolic Calcium Ion Concentration Involved In Phospholipase C-activating G Protein-Coupled Signaling Pathway (GO:0051482),1/27,0.173989986902528,0.316108840265129,0,0,5.44862637362637,9.52832638792415,LPAR6
Positive Regulation Of Immune System Process (GO:0002684),1/27,0.173989986902528,0.316108840265129,0,0,5.44862637362637,9.52832638792415,RSAD2
Myeloid Cell Development (GO:0061515),1/27,0.173989986902528,0.316108840265129,0,0,5.44862637362637,9.52832638792415,MYB
Negative Regulation Of Cellular Response To Insulin Stimulus (GO:1900077),1/27,0.173989986902528,0.316108840265129,0,0,5.44862637362637,9.52832638792415,IRS1
Positive Regulation Of T Cell Activation (GO:0050870),2/107,0.17434695865845,0.316108840265129,0,0,2.70695443645084,4.72825883416242,CD70;IL6ST
Positive Regulation Of Autophagy (GO:0010508),2/107,0.17434695865845,0.316108840265129,0,0,2.70695443645084,4.72825883416242,ZC3H12A;MID2
Regulation Of Angiogenesis (GO:0045765),3/205,0.176336639192002,0.318666232030615,0,0,2.11547567800258,3.67111269377862,STAT1;ZC3H12A;GAB1
Regulation Of Glucose Metabolic Process (GO:0010906),1/28,0.179821221262759,0.318666232030615,0,0,5.24656084656085,9.002007846107,IRS1
RNA Phosphodiester Bond Hydrolysis (GO:0090501),1/28,0.179821221262759,0.318666232030615,0,0,5.24656084656085,9.002007846107,ZC3H12A
Negative Regulation Of Type II Interferon Production (GO:0032689),1/28,0.179821221262759,0.318666232030615,0,0,5.24656084656085,9.002007846107,ZC3H12A
Nuclear-Transcribed mRNA Catabolic Process, Nonsense-Mediated Decay (GO:0000184),1/28,0.179821221262759,0.318666232030615,0,0,5.24656084656085,9.002007846107,ZC3H12A
Regulation Of Protein Localization To Membrane (GO:1905475),1/28,0.179821221262759,0.318666232030615,0,0,5.24656084656085,9.002007846107,GBP1
Regulation Of Protein Targeting To Membrane (GO:0090313),1/28,0.179821221262759,0.318666232030615,0,0,5.24656084656085,9.002007846107,ITGAM
Positive Regulation Of Fibroblast Proliferation (GO:0048146),1/28,0.179821221262759,0.318666232030615,0,0,5.24656084656085,9.002007846107,CDK6
Glycosaminoglycan Metabolic Process (GO:0030203),1/28,0.179821221262759,0.318666232030615,0,0,5.24656084656085,9.002007846107,HS3ST1
Positive Regulation Of Protein Import Into Nucleus (GO:0042307),1/28,0.179821221262759,0.318666232030615,0,0,5.24656084656085,9.002007846107,ZC3H12A
Protein Localization To Golgi Apparatus (GO:0034067),1/28,0.179821221262759,0.318666232030615,0,0,5.24656084656085,9.002007846107,GBP5
Pyroptosis (GO:0070269),1/28,0.179821221262759,0.318666232030615,0,0,5.24656084656085,9.002007846107,IFI27
Regulation Of JNK Cascade (GO:0046328),2/110,0.18191273076758,0.321766691075737,0,0,2.63136157740474,4.48444062613386,TRAF4;WNT16
Negative Regulation Of Transmembrane Receptor Protein Serine/Threonine Kinase Signaling Pathway (GO:0090101),2/111,0.184445650548121,0.322847498366805,0,0,2.60708864101379,4.40702377512882,SKIL;GPR155
Cardiac Muscle Cell Action Potential (GO:0086001),1/29,0.185611579826187,0.322847498366805,0,0,5.05892857142857,8.51973689865339,KCNH2
Positive Regulation Of Endopeptidase Activity (GO:0010950),1/29,0.185611579826187,0.322847498366805,0,0,5.05892857142857,8.51973689865339,AIM2
Positive Regulation Of Neural Precursor Cell Proliferation (GO:2000179),1/29,0.185611579826187,0.322847498366805,0,0,5.05892857142857,8.51973689865339,HAPLN3
Heterotypic Cell-Cell Adhesion (GO:0034113),1/29,0.185611579826187,0.322847498366805,0,0,5.05892857142857,8.51973689865339,JAM3
Integrated Stress Response Signaling (GO:0140467),1/29,0.185611579826187,0.322847498366805,0,0,5.05892857142857,8.51973689865339,EIF2AK2
Positive Regulation Of Viral Genome Replication (GO:0045070),1/29,0.185611579826187,0.322847498366805,0,0,5.05892857142857,8.51973689865339,IFIT1
Maintenance Of Blood-Brain Barrier (GO:0035633),1/29,0.185611579826187,0.322847498366805,0,0,5.05892857142857,8.51973689865339,JAM3
Modified Amino Acid Transport (GO:0072337),1/29,0.185611579826187,0.322847498366805,0,0,5.05892857142857,8.51973689865339,SLC7A11
Protein Deubiquitination (GO:0016579),2/112,0.186983733927155,0.32463412108017,0,0,2.58325703073905,4.33143399070488,ZC3H12A;USP18
Proteasome-Mediated Ubiquitin-Dependent Protein Catabolic Process (GO:0043161),4/319,0.188592061072638,0.325625728057561,0,0,1.81151662611517,3.02191588530596,IFI27;MAN1A1;AGAP3;TNFSF13B
Negative Regulation Of Interleukin-1 Production (GO:0032692),1/30,0.191361347094401,0.325625728057561,0,0,4.88423645320197,8.07653319521709,ZC3H12A
GPI Anchor Biosynthetic Process (GO:0006506),1/30,0.191361347094401,0.325625728057561,0,0,4.88423645320197,8.07653319521709,PGAP1
Negative Regulation Of Myeloid Leukocyte Differentiation (GO:0002762),1/30,0.191361347094401,0.325625728057561,0,0,4.88423645320197,8.07653319521709,CDK6
Regulation Of Potassium Ion Transport (GO:0043266),1/30,0.191361347094401,0.325625728057561,0,0,4.88423645320197,8.07653319521709,KCNH2
Cardiac Muscle Cell Action Potential Involved In Contraction (GO:0086002),1/30,0.191361347094401,0.325625728057561,0,0,4.88423645320197,8.07653319521709,KCNH2
Phagocytosis, Engulfment (GO:0006911),1/30,0.191361347094401,0.325625728057561,0,0,4.88423645320197,8.07653319521709,ITGAM
Positive Regulation Of Interleukin-10 Production (GO:0032733),1/30,0.191361347094401,0.325625728057561,0,0,4.88423645320197,8.07653319521709,ISG15
Positive Regulation Of Lipid Kinase Activity (GO:0090218),1/30,0.191361347094401,0.325625728057561,0,0,4.88423645320197,8.07653319521709,IRS1
Mitotic G2 DNA Damage Checkpoint Signaling (GO:0007095),1/30,0.191361347094401,0.325625728057561,0,0,4.88423645320197,8.07653319521709,TNFSF13B
Regulation Of Calcium-Mediated Signaling (GO:0050848),1/30,0.191361347094401,0.325625728057561,0,0,4.88423645320197,8.07653319521709,GBP1
Regulation Of Interleukin-6 Production (GO:0032675),2/114,0.192074606810213,0.325661630645784,0,0,2.53687050359712,4.18551010281963,ZC3H12A;TLR7
Protein Modification By Small Protein Removal (GO:0070646),2/114,0.192074606810213,0.325661630645784,0,0,2.53687050359712,4.18551010281963,ZC3H12A;USP18
Protein Ubiquitination (GO:0016567),5/434,0.192494658099507,0.325786822431,0,0,1.66512409159468,2.74360311225195,HERC5;ISG15;BRCA2;HERC6;TNFSF13B
B Cell Proliferation (GO:0042100),1/31,0.197070805603298,0.328218810748147,0,0,4.72119047619048,7.66812072496225,CD70
Regulation Of Macrophage Activation (GO:0043030),1/31,0.197070805603298,0.328218810748147,0,0,4.72119047619048,7.66812072496225,ZC3H12A
Regulation Of Response To Biotic Stimulus (GO:0002831),1/31,0.197070805603298,0.328218810748147,0,0,4.72119047619048,7.66812072496225,HERC5
Phospholipid Translocation (GO:0045332),1/31,0.197070805603298,0.328218810748147,0,0,4.72119047619048,7.66812072496225,PLSCR1
Positive Regulation Of Rho Protein Signal Transduction (GO:0035025),1/31,0.197070805603298,0.328218810748147,0,0,4.72119047619048,7.66812072496225,LPAR6
Positive Regulation Of Glucose Transmembrane Transport (GO:0010828),1/31,0.197070805603298,0.328218810748147,0,0,4.72119047619048,7.66812072496225,IRS1
Positive Regulation Of Leukocyte Migration (GO:0002687),1/31,0.197070805603298,0.328218810748147,0,0,4.72119047619048,7.66812072496225,JAM3
Toll-Like Receptor Signaling Pathway (GO:0002224),1/31,0.197070805603298,0.328218810748147,0,0,4.72119047619048,7.66812072496225,TLR7
Receptor Signaling Pathway Via STAT (GO:0097696),1/31,0.197070805603298,0.328218810748147,0,0,4.72119047619048,7.66812072496225,STAT1
Protein-Containing Complex Assembly (GO:0065003),4/328,0.201495329262131,0.334994884868667,0,0,1.76038568982608,2.82011864764885,NT5C3A;AIM2;ZC3H12A;GBP1
Regulation Of Protein Binding (GO:0043393),2/118,0.202309821871102,0.335131989761915,0,0,2.44889605556934,3.913225659666,IFIT1;IFIT2
Negative Regulation Of Osteoblast Differentiation (GO:0045668),1/32,0.202740235905599,0.335131989761915,0,0,4.56866359447005,7.29080926097193,CDK6
Phosphatidylinositol 3-Kinase Signaling (GO:0014065),1/32,0.202740235905599,0.335131989761915,0,0,4.56866359447005,7.29080926097193,IRS1
Proteasomal Protein Catabolic Process (GO:0010498),3/220,0.203002374244731,0.335131989761915,0,0,1.96774193548387,3.1376385115334,IFI27;AGAP3;TNFSF13B
Positive Regulation Of Angiogenesis (GO:0045766),2/119,0.204878677545455,0.337637190140584,0,0,2.42784234151141,3.84894900282243,ZC3H12A;GAB1
Negative Regulation Of Endocytosis (GO:0045806),1/33,0.208369916666779,0.338062226867998,0,0,4.42566964285714,6.9413987698477,PLSCR1
Cardiac Muscle Contraction (GO:0060048),1/33,0.208369916666779,0.338062226867998,0,0,4.42566964285714,6.9413987698477,KCNH2
Positive Regulation Of Notch Signaling Pathway (GO:0045747),1/33,0.208369916666779,0.338062226867998,0,0,4.42566964285714,6.9413987698477,IL6ST
Glycolipid Metabolic Process (GO:0006664),1/33,0.208369916666779,0.338062226867998,0,0,4.42566964285714,6.9413987698477,PGAP1
Ubiquitin-Dependent Protein Catabolic Process Via The Multivesicular Body Sorting Pathway (GO:0043162),1/33,0.208369916666779,0.338062226867998,0,0,4.42566964285714,6.9413987698477,MVB12B
Inositol Lipid-Mediated Signaling (GO:0048017),1/33,0.208369916666779,0.338062226867998,0,0,4.42566964285714,6.9413987698477,PLCB3
Positive Regulation Of Small Molecule Metabolic Process (GO:0062013),1/33,0.208369916666779,0.338062226867998,0,0,4.42566964285714,6.9413987698477,IRS1
ncRNA Catabolic Process (GO:0034661),1/33,0.208369916666779,0.338062226867998,0,0,4.42566964285714,6.9413987698477,ZC3H12A
Regulation Of Cell Adhesion Mediated By Integrin (GO:0033628),1/33,0.208369916666779,0.338062226867998,0,0,4.42566964285714,6.9413987698477,JAM3
Protein Polyubiquitination (GO:0000209),3/226,0.213924605565951,0.341827635294513,0,0,1.91421329693897,2.95196888417198,IFI27;TRAF4;TNFSF13B
DNA Damage Checkpoint Signaling (GO:0000077),1/34,0.213960124536098,0.341827635294513,0,0,4.29134199134199,6.61710179399682,PARP9
Negative Regulation Of Interleukin-6 Production (GO:0032715),1/34,0.213960124536098,0.341827635294513,0,0,4.29134199134199,6.61710179399682,ZC3H12A
Regulation Of Phosphatidylinositol 3-Kinase Activity (GO:0043551),1/34,0.213960124536098,0.341827635294513,0,0,4.29134199134199,6.61710179399682,IRS1
Cellular Response To Vascular Endothelial Growth Factor Stimulus (GO:0035924),1/34,0.213960124536098,0.341827635294513,0,0,4.29134199134199,6.61710179399682,GAB1
Positive Regulation Of Carbohydrate Metabolic Process (GO:0045913),1/34,0.213960124536098,0.341827635294513,0,0,4.29134199134199,6.61710179399682,IRS1
Glial Cell Differentiation (GO:0010001),1/34,0.213960124536098,0.341827635294513,0,0,4.29134199134199,6.61710179399682,HAPLN3
Positive Regulation Of Neuron Death (GO:1901216),1/34,0.213960124536098,0.341827635294513,0,0,4.29134199134199,6.61710179399682,ITGAM
Purine Nucleotide Metabolic Process (GO:0006163),1/34,0.213960124536098,0.341827635294513,0,0,4.29134199134199,6.61710179399682,CD38
Regulation Of Cellular Senescence (GO:2000772),1/35,0.219511134377592,0.345996612142904,0,0,4.16491596638655,6.31547999514749,CDK6
Action Potential (GO:0001508),1/35,0.219511134377592,0.345996612142904,0,0,4.16491596638655,6.31547999514749,KCNH2
Adherens Junction Organization (GO:0034332),1/35,0.219511134377592,0.345996612142904,0,0,4.16491596638655,6.31547999514749,JAM3
Neutral Amino Acid Transport (GO:0015804),1/35,0.219511134377592,0.345996612142904,0,0,4.16491596638655,6.31547999514749,SLC7A11
Response To Exogenous dsRNA (GO:0043330),1/35,0.219511134377592,0.345996612142904,0,0,4.16491596638655,6.31547999514749,IFIT1
Dendrite Morphogenesis (GO:0048813),1/35,0.219511134377592,0.345996612142904,0,0,4.16491596638655,6.31547999514749,BTBD3
Endoderm Formation (GO:0001706),1/35,0.219511134377592,0.345996612142904,0,0,4.16491596638655,6.31547999514749,SOX7
Regulation Of Cardiac Muscle Contraction (GO:0055117),1/35,0.219511134377592,0.345996612142904,0,0,4.16491596638655,6.31547999514749,ZC3H12A
Cellular Response To Starvation (GO:0009267),2/126,0.222953285228575,0.349994791975038,0,0,2.28997447203527,3.43677768699871,ZC3H12A;EIF2AK2
Positive Regulation Of Intracellular Protein Transport (GO:0090316),2/126,0.222953285228575,0.349994791975038,0,0,2.28997447203527,3.43677768699871,ITGAM;ZC3H12A
Regulation Of Glucose Import (GO:0046324),1/36,0.225023219070029,0.349994791975038,0,0,4.04571428571429,6.03439196488317,IRS1
Regulation Of Intracellular Protein Transport (GO:0033157),1/36,0.225023219070029,0.349994791975038,0,0,4.04571428571429,6.03439196488317,IFI27
Negative Regulation Of Sequestering Of Calcium Ion (GO:0051283),1/36,0.225023219070029,0.349994791975038,0,0,4.04571428571429,6.03439196488317,PLCB3
Positive Regulation Of Myeloid Cell Differentiation (GO:0045639),1/36,0.225023219070029,0.349994791975038,0,0,4.04571428571429,6.03439196488317,STAT1
Receptor Signaling Pathway Via JAK-STAT (GO:0007259),1/36,0.225023219070029,0.349994791975038,0,0,4.04571428571429,6.03439196488317,STAT1
Negative Regulation Of T Cell Proliferation (GO:0042130),1/36,0.225023219070029,0.349994791975038,0,0,4.04571428571429,6.03439196488317,TNFRSF21
Regulation Of Response To External Stimulus (GO:0032101),2/127,0.225546552825841,0.350229878232866,0,0,2.27153956834532,3.38284191531957,HERC5;USP18
Regulation Of Apoptotic Process (GO:0042981),7/705,0.230198879803339,0.354987475158249,0,0,1.43402258050721,2.10630907102744,GLS2;STAT1;IFI6;CD38;IL6ST;IFIT3;IFIT2
Negative Regulation Of Endothelial Cell Proliferation (GO:0001937),1/37,0.230496649651105,0.354987475158249,0,0,3.93313492063492,5.77195003596807,STAT1
Regulation Of Ossification (GO:0030278),1/37,0.230496649651105,0.354987475158249,0,0,3.93313492063492,5.77195003596807,ANKH
Regulation Of p38MAPK Cascade (GO:1900744),1/37,0.230496649651105,0.354987475158249,0,0,3.93313492063492,5.77195003596807,ZC3H12A
Positive Regulation Of Immune Effector Process (GO:0002699),1/37,0.230496649651105,0.354987475158249,0,0,3.93313492063492,5.77195003596807,DDX60
Positive Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050731),2/130,0.233339512955078,0.35866191465574,0,0,2.2179631294964,3.22771468478445,IL6ST;PARP9
Regulation Of Intracellular Transport (GO:0032386),1/38,0.235931695187995,0.35866191465574,0,0,3.82664092664093,5.52648435453786,MX2
Amino Acid Catabolic Process (GO:0009063),1/38,0.235931695187995,0.35866191465574,0,0,3.82664092664093,5.52648435453786,CARNS1
Regulation Of Neurotransmitter Secretion (GO:0046928),1/38,0.235931695187995,0.35866191465574,0,0,3.82664092664093,5.52648435453786,MYOF
Regulation Of Protein Import Into Nucleus (GO:0042306),1/38,0.235931695187995,0.35866191465574,0,0,3.82664092664093,5.52648435453786,ZC3H12A
Response To cAMP (GO:0051591),1/38,0.235931695187995,0.35866191465574,0,0,3.82664092664093,5.52648435453786,STAT1
Positive Regulation Of Bone Mineralization (GO:0030501),1/38,0.235931695187995,0.35866191465574,0,0,3.82664092664093,5.52648435453786,ISG15
Lymphocyte Proliferation (GO:0046651),1/38,0.235931695187995,0.35866191465574,0,0,3.82664092664093,5.52648435453786,CD70
Negative Regulation Of Lymphocyte Proliferation (GO:0050672),1/39,0.241328623044065,0.360460689340421,0,0,3.72575187969925,5.29651282621738,TNFRSF21
Negative Regulation Of Proteasomal Protein Catabolic Process (GO:1901799),1/39,0.241328623044065,0.360460689340421,0,0,3.72575187969925,5.29651282621738,LAMP3
Anterograde Axonal Transport (GO:0008089),1/39,0.241328623044065,0.360460689340421,0,0,3.72575187969925,5.29651282621738,KIF1C
Regulation Of Monoatomic Cation Transmembrane Transport (GO:1904062),1/39,0.241328623044065,0.360460689340421,0,0,3.72575187969925,5.29651282621738,KCNH2
Regulation Of Nitric Oxide Biosynthetic Process (GO:0045428),1/39,0.241328623044065,0.360460689340421,0,0,3.72575187969925,5.29651282621738,ZC3H12A
Axonal Transport (GO:0098930),1/39,0.241328623044065,0.360460689340421,0,0,3.72575187969925,5.29651282621738,SYBU
Carboxylic Acid Transmembrane Transport (GO:1905039),1/39,0.241328623044065,0.360460689340421,0,0,3.72575187969925,5.29651282621738,SLC7A11
Positive Regulation Of ATP-dependent Activity (GO:0032781),1/39,0.241328623044065,0.360460689340421,0,0,3.72575187969925,5.29651282621738,PLSCR1
Release Of Sequestered Calcium Ion Into Cytosol (GO:0051209),1/39,0.241328623044065,0.360460689340421,0,0,3.72575187969925,5.29651282621738,PLCB3
Positive Regulation Of Intracellular Transport (GO:0032388),1/39,0.241328623044065,0.360460689340421,0,0,3.72575187969925,5.29651282621738,PGAP1
Negative Regulation Of Cell-Substrate Adhesion (GO:0010812),1/39,0.241328623044065,0.360460689340421,0,0,3.72575187969925,5.29651282621738,GBP1
Regulation Of Autophagy (GO:0010506),3/241,0.241743148979807,0.360507612028524,0,0,1.79219948849105,2.54470728553016,LAMP3;ZC3H12A;MID2
L-alpha-amino Acid Transmembrane Transport (GO:1902475),1/40,0.246687698575475,0.365563975369326,0,0,3.63003663003663,5.08071586632362,SLC7A11
Negative Regulation Of Secretion By Cell (GO:1903531),1/40,0.246687698575475,0.365563975369326,0,0,3.63003663003663,5.08071586632362,RSAD2
Cellular Response To Heat (GO:0034605),1/40,0.246687698575475,0.365563975369326,0,0,3.63003663003663,5.08071586632362,IER5
Endothelial Cell Migration (GO:0043542),1/40,0.246687698575475,0.365563975369326,0,0,3.63003663003663,5.08071586632362,STAT1
Positive Regulation Of Gene Expression (GO:0010628),5/480,0.251018644471998,0.368230812889128,0,0,1.50030959752322,2.07377002715062,PLSCR1;LAMP3;ZC3H12A;EIF2AK2;WNT16
Positive Regulation Of DNA-binding Transcription Factor Activity (GO:0051091),3/246,0.251150846581864,0.368230812889128,0,0,1.75487564859546,2.42471438261059,AIM2;EIF2AK2;MID2
Regulation Of Heart Rate By Cardiac Conduction (GO:0086091),1/41,0.252009185441656,0.368230812889128,0,0,3.53910714285714,4.8779150707317,KCNH2
Acylglycerol Metabolic Process (GO:0006639),1/41,0.252009185441656,0.368230812889128,0,0,3.53910714285714,4.8779150707317,ABHD6
Response To Amino Acid Starvation (GO:1990928),1/41,0.252009185441656,0.368230812889128,0,0,3.53910714285714,4.8779150707317,EIF2AK2
Heart Contraction (GO:0060047),1/41,0.252009185441656,0.368230812889128,0,0,3.53910714285714,4.8779150707317,KCNH2
Positive Regulation Of Ossification (GO:0045778),1/41,0.252009185441656,0.368230812889128,0,0,3.53910714285714,4.8779150707317,ISG15
Visual System Development (GO:0150063),1/41,0.252009185441656,0.368230812889128,0,0,3.53910714285714,4.8779150707317,ITGAM
Positive Regulation Of Viral Process (GO:0048524),1/41,0.252009185441656,0.368230812889128,0,0,3.53910714285714,4.8779150707317,IFIT1
Positive Regulation Of Macromolecule Metabolic Process (GO:0010604),4/364,0.255440158938565,0.37077034922006,0,0,1.58142741281427,2.15828011726926,PLSCR1;LAMP3;ZC3H12A;WNT16
DNA Integrity Checkpoint Signaling (GO:0031570),1/42,0.257293345420509,0.37077034922006,0,0,3.45261324041812,4.68705513412296,PARP9
Amino Acid Transmembrane Transport (GO:0003333),1/42,0.257293345420509,0.37077034922006,0,0,3.45261324041812,4.68705513412296,SLC7A11
Cellular Response To Amino Acid Starvation (GO:0034198),1/42,0.257293345420509,0.37077034922006,0,0,3.45261324041812,4.68705513412296,EIF2AK2
Cellular Response To Glucose Starvation (GO:0042149),1/42,0.257293345420509,0.37077034922006,0,0,3.45261324041812,4.68705513412296,ZC3H12A
Ceramide Biosynthetic Process (GO:0046513),1/42,0.257293345420509,0.37077034922006,0,0,3.45261324041812,4.68705513412296,CERS6
Substantia Nigra Development (GO:0021762),1/42,0.257293345420509,0.37077034922006,0,0,3.45261324041812,4.68705513412296,GNB4
Keratinocyte Differentiation (GO:0030216),1/42,0.257293345420509,0.37077034922006,0,0,3.45261324041812,4.68705513412296,WNT16
Potassium Ion Import Across Plasma Membrane (GO:1990573),1/42,0.257293345420509,0.37077034922006,0,0,3.45261324041812,4.68705513412296,KCNH2
Positive Regulation Of Biomineral Tissue Development (GO:0070169),1/43,0.262540438431628,0.376028238301616,0,0,3.3702380952381,4.50718844797465,ISG15
Positive Regulation Of Cell-Matrix Adhesion (GO:0001954),1/43,0.262540438431628,0.376028238301616,0,0,3.3702380952381,4.50718844797465,CDK6
Positive Regulation Of miRNA Transcription (GO:1902895),1/43,0.262540438431628,0.376028238301616,0,0,3.3702380952381,4.50718844797465,MYB
mRNA Destabilization (GO:0061157),1/43,0.262540438431628,0.376028238301616,0,0,3.3702380952381,4.50718844797465,ZC3H12A
Regulation Of Insulin Receptor Signaling Pathway (GO:0046626),1/44,0.26775072268597,0.381170090843415,0,0,3.29169435215947,4.33746193003851,IRS1
Neural Crest Cell Development (GO:0014032),1/44,0.26775072268597,0.381170090843415,0,0,3.29169435215947,4.33746193003851,TAPT1
Positive Regulation Of Nucleocytoplasmic Transport (GO:0046824),1/44,0.26775072268597,0.381170090843415,0,0,3.29169435215947,4.33746193003851,ZC3H12A
Regulation Of Cell-Substrate Adhesion (GO:0010810),1/44,0.26775072268597,0.381170090843415,0,0,3.29169435215947,4.33746193003851,FBLN2
Regulation Of Gene Expression (GO:0010468),10/1127,0.272264515807056,0.385040347393391,0,0,1.28082992202396,1.66633564979363,BTNL9;PLSCR1;CDK6;LAMP3;MYB;ZC3H12A;BRCA2;WNT16;PARP9;SOX7
I-kappaB kinase/NF-kappaB Signaling (GO:0007249),1/45,0.272924454528578,0.385040347393391,0,0,3.21672077922078,4.17710572454693,TLR7
Regulation Of Stem Cell Differentiation (GO:2000736),1/45,0.272924454528578,0.385040347393391,0,0,3.21672077922078,4.17710572454693,EIF2AK2
Epidermal Growth Factor Receptor Signaling Pathway (GO:0007173),1/45,0.272924454528578,0.385040347393391,0,0,3.21672077922078,4.17710572454693,GAB1
Positive Regulation Of mRNA Catabolic Process (GO:0061014),1/45,0.272924454528578,0.385040347393391,0,0,3.21672077922078,4.17710572454693,ZC3H12A
Hexose Metabolic Process (GO:0019318),1/45,0.272924454528578,0.385040347393391,0,0,3.21672077922078,4.17710572454693,OAS1
Protein Glycosylation (GO:0006486),2/147,0.277694196303584,0.386493703308274,0,0,1.95623914661374,2.50640164055523,MGAT3;GALNTL6
B Cell Receptor Signaling Pathway (GO:0050853),1/46,0.278061888565039,0.386493703308274,0,0,3.14507936507936,4.02542346582697,CD38
Regulation Of Fibroblast Proliferation (GO:0048145),1/46,0.278061888565039,0.386493703308274,0,0,3.14507936507936,4.02542346582697,CDK6
Regulation Of mRNA Catabolic Process (GO:0061013),1/46,0.278061888565039,0.386493703308274,0,0,3.14507936507936,4.02542346582697,ZC3H12A
Amino Acid Transport (GO:0006865),1/46,0.278061888565039,0.386493703308274,0,0,3.14507936507936,4.02542346582697,SLC7A11
Cardiac Conduction (GO:0061337),1/46,0.278061888565039,0.386493703308274,0,0,3.14507936507936,4.02542346582697,KCNH2
Replication Fork Processing (GO:0031297),1/46,0.278061888565039,0.386493703308274,0,0,3.14507936507936,4.02542346582697,BRCA2
Epithelial Cell Migration (GO:0010631),1/46,0.278061888565039,0.386493703308274,0,0,3.14507936507936,4.02542346582697,STAT1
Mitotic G2/M Transition Checkpoint (GO:0044818),1/46,0.278061888565039,0.386493703308274,0,0,3.14507936507936,4.02542346582697,TNFSF13B
Negative Regulation Of Cellular Metabolic Process (GO:0031324),1/46,0.278061888565039,0.386493703308274,0,0,3.14507936507936,4.02542346582697,CDK6
Regulation Of Interleukin-2 Production (GO:0032663),1/47,0.283163277687363,0.39184800632913,0,0,3.07655279503106,3.88178386441753,GBP1
Positive Regulation Of Smooth Muscle Cell Proliferation (GO:0048661),1/47,0.283163277687363,0.39184800632913,0,0,3.07655279503106,3.88178386441753,STAT1
Protein Monoubiquitination (GO:0006513),1/47,0.283163277687363,0.39184800632913,0,0,3.07655279503106,3.88178386441753,TNFSF13B
DNA Damage Response (GO:0006974),4/384,0.286610986798968,0.394220013763881,0,0,1.49665770265079,1.87026751091795,AIM2;ZC3H12A;IRF7;TNFSF13B
Cellular Defense Response (GO:0006968),1/48,0.28822887297508,0.394220013763881,0,0,3.01094224924012,3.74561341247702,LGALS3BP
Cellular Response To Mechanical Stimulus (GO:0071260),1/48,0.28822887297508,0.394220013763881,0,0,3.01094224924012,3.74561341247702,TLR7
Cellular Response To Radiation (GO:0071478),1/48,0.28822887297508,0.394220013763881,0,0,3.01094224924012,3.74561341247702,BRCA2
Retrograde Vesicle-Mediated Transport, Golgi To Endoplasmic Reticulum (GO:0006890),1/48,0.28822887297508,0.394220013763881,0,0,3.01094224924012,3.74561341247702,KIF1C
Post-Translational Protein Modification (GO:0043687),1/48,0.28822887297508,0.394220013763881,0,0,3.01094224924012,3.74561341247702,PARP9
Myelination (GO:0042552),1/48,0.28822887297508,0.394220013763881,0,0,3.01094224924012,3.74561341247702,TNFRSF21
Negative Regulation Of ERK1 And ERK2 Cascade (GO:0070373),1/48,0.28822887297508,0.394220013763881,0,0,3.01094224924012,3.74561341247702,GBP1
Negative Regulation Of Transcription By RNA Polymerase II (GO:0000122),7/763,0.292806436302079,0.398781282238863,0,0,1.31999723604201,1.62127804529088,IFI27;SATB1;STAT1;GFI1;MYB;IRF7;PARP9
Erythrocyte Differentiation (GO:0030218),1/49,0.29325892381434,0.398781282238863,0,0,2.94806547619048,3.61639003633644,MYB
Unsaturated Fatty Acid Metabolic Process (GO:0033559),1/49,0.29325892381434,0.398781282238863,0,0,2.94806547619048,3.61639003633644,ABHD6
Negative Regulation Of T Cell Activation (GO:0050868),1/49,0.29325892381434,0.398781282238863,0,0,2.94806547619048,3.61639003633644,TNFRSF21
Negative Regulation Of DNA-templated Transcription (GO:0045892),9/1025,0.297646578003854,0.403242400582433,0,0,1.26451771653543,1.53240386786106,IFI27;SATB1;STAT1;GFI1;MYB;IRF7;CD38;PARP9;SOX7
Positive Regulation Of Cell Death (GO:0010942),1/50,0.298253677795296,0.403242400582433,0,0,2.88775510204082,3.49363756094843,ITGAM
Positive Regulation Of Fat Cell Differentiation (GO:0045600),1/50,0.298253677795296,0.403242400582433,0,0,2.88775510204082,3.49363756094843,ZC3H12A
Negative Regulation Of Cell Projection Organization (GO:0031345),1/50,0.298253677795296,0.403242400582433,0,0,2.88775510204082,3.49363756094843,GFI1
Regulation Of Stress-Activated MAPK Cascade (GO:0032872),1/51,0.303213380924488,0.407605416357062,0,0,2.82985714285714,3.37692086352784,EIF2AK2
Regulation Of Substrate Adhesion-Dependent Cell Spreading (GO:1900024),1/51,0.303213380924488,0.407605416357062,0,0,2.82985714285714,3.37692086352784,GBP1
Positive Regulation Of Ras Protein Signal Transduction (GO:0046579),1/51,0.303213380924488,0.407605416357062,0,0,2.82985714285714,3.37692086352784,LPAR6
Positive Regulation Of Leukocyte Mediated Cytotoxicity (GO:0001912),1/51,0.303213380924488,0.407605416357062,0,0,2.82985714285714,3.37692086352784,ITGAM
Arachidonic Acid Metabolic Process (GO:0019369),1/52,0.308138277325174,0.411288112004239,0,0,2.77422969187675,3.26584162637756,ABHD6
Regulation Of Protein Localization To Nucleus (GO:1900180),1/52,0.308138277325174,0.411288112004239,0,0,2.77422969187675,3.26584162637756,PARP9
Cell Cycle G1/S Phase Transition (GO:0044843),1/52,0.308138277325174,0.411288112004239,0,0,2.77422969187675,3.26584162637756,CDK6
Cellular Response To Ionizing Radiation (GO:0071479),1/52,0.308138277325174,0.411288112004239,0,0,2.77422969187675,3.26584162637756,BRCA2
Icosanoid Metabolic Process (GO:0006690),1/52,0.308138277325174,0.411288112004239,0,0,2.77422969187675,3.26584162637756,ABHD6
Regulation Of Cyclin-Dependent Protein Kinase Activity (GO:1904029),1/53,0.31302860958344,0.414873129039461,0,0,2.72074175824176,3.16003459493971,HERC5
Regulation Of Proteasomal Protein Catabolic Process (GO:0061136),1/53,0.31302860958344,0.414873129039461,0,0,2.72074175824176,3.16003459493971,LAMP3
Carboxylic Acid Transport (GO:0046942),1/53,0.31302860958344,0.414873129039461,0,0,2.72074175824176,3.16003459493971,SLC16A4
Glycoprotein Metabolic Process (GO:0009100),1/53,0.31302860958344,0.414873129039461,0,0,2.72074175824176,3.16003459493971,MAN1A1
Protein Homotetramerization (GO:0051289),1/53,0.31302860958344,0.414873129039461,0,0,2.72074175824176,3.16003459493971,GBP5
Regulation Of Macromolecule Metabolic Process (GO:0060255),2/162,0.316733911225474,0.415764780795495,0,0,1.7714928057554,2.03667332892541,CDK6;ZC3H12A
ERBB Signaling Pathway (GO:0038127),1/54,0.317884618587537,0.415764780795495,0,0,2.66927223719677,3.05916428233162,GAB1
Negative Regulation Of Neuron Projection Development (GO:0010977),1/54,0.317884618587537,0.415764780795495,0,0,2.66927223719677,3.05916428233162,GFI1
Negative Regulation Of Protein Catabolic Process (GO:0042177),1/54,0.317884618587537,0.415764780795495,0,0,2.66927223719677,3.05916428233162,LAMP3
Negative Regulation Of Protein Modification By Small Protein Conjugation Or Removal (GO:1903321),1/54,0.317884618587537,0.415764780795495,0,0,2.66927223719677,3.05916428233162,ISG15
Negative Regulation Of Protein Ubiquitination (GO:0031397),1/54,0.317884618587537,0.415764780795495,0,0,2.66927223719677,3.05916428233162,ISG15
Regulation Of Smooth Muscle Cell Proliferation (GO:0048660),1/54,0.317884618587537,0.415764780795495,0,0,2.66927223719677,3.05916428233162,STAT1
Epidermal Cell Differentiation (GO:0009913),1/54,0.317884618587537,0.415764780795495,0,0,2.66927223719677,3.05916428233162,WNT16
Protein K63-linked Ubiquitination (GO:0070534),1/54,0.317884618587537,0.415764780795495,0,0,2.66927223719677,3.05916428233162,TRAF4
Monoatomic Cation Transmembrane Transport (GO:0098655),3/281,0.318119704753195,0.415764780795495,0,0,1.53120112605568,1.75372681434546,KCNH2;KCNC4;KCNN4
Positive Regulation Of Cell Differentiation (GO:0045597),3/283,0.321976521895308,0.420221785164334,0,0,1.52010869565217,1.72270368943077,IFITM1;ZC3H12A;IL6ST
Ceramide Metabolic Process (GO:0006672),1/55,0.322706543458305,0.420591215227514,0,0,2.61970899470899,2.96292205518052,CERS6
Inorganic Cation Transmembrane Transport (GO:0098662),3/284,0.323905153566742,0.421569501391846,0,0,1.51462169271236,1.70743991353131,KCNH2;KCNC4;KCNN4
Nucleotide-Excision Repair (GO:0006289),1/56,0.327494621774838,0.422733112606478,0,0,2.57194805194805,2.87102354901669,BRCA2
Pattern Recognition Receptor Signaling Pathway (GO:0002221),1/56,0.327494621774838,0.422733112606478,0,0,2.57194805194805,2.87102354901669,TLR7
Peptide Metabolic Process (GO:0006518),1/56,0.327494621774838,0.422733112606478,0,0,2.57194805194805,2.87102354901669,MGAT3
Regulation Of Reactive Oxygen Species Metabolic Process (GO:2000377),1/56,0.327494621774838,0.422733112606478,0,0,2.57194805194805,2.87102354901669,ZC3H12A
Positive Regulation Of Cellular Metabolic Process (GO:0031325),1/56,0.327494621774838,0.422733112606478,0,0,2.57194805194805,2.87102354901669,ZC3H12A
Mitotic DNA Damage Checkpoint Signaling (GO:0044773),1/56,0.327494621774838,0.422733112606478,0,0,2.57194805194805,2.87102354901669,TNFSF13B
Double-Strand Break Repair (GO:0006302),2/168,0.332232772884511,0.425369242438877,0,0,1.70694287943139,1.88091352916921,BRCA2;PARP9
Signal Transduction In Response To DNA Damage (GO:0042770),1/57,0.332249089471386,0.425369242438877,0,0,2.52589285714286,2.78320637554697,PARP9
Striated Muscle Contraction (GO:0006941),1/57,0.332249089471386,0.425369242438877,0,0,2.52589285714286,2.78320637554697,KCNH2
Post-Transcriptional Regulation Of Gene Expression (GO:0010608),1/57,0.332249089471386,0.425369242438877,0,0,2.52589285714286,2.78320637554697,PARP9
Membrane Lipid Biosynthetic Process (GO:0046467),1/57,0.332249089471386,0.425369242438877,0,0,2.52589285714286,2.78320637554697,CERS6
Myeloid Cell Differentiation (GO:0030099),1/57,0.332249089471386,0.425369242438877,0,0,2.52589285714286,2.78320637554697,MYB
Regulation Of Neuron Death (GO:1901214),1/58,0.336970180744553,0.429078403356731,0,0,2.48145363408521,2.69922808194526,ITGAM
Regulation Of Phagocytosis (GO:0050764),1/58,0.336970180744553,0.429078403356731,0,0,2.48145363408521,2.69922808194526,PLSCR1
Renal System Development (GO:0072001),1/58,0.336970180744553,0.429078403356731,0,0,2.48145363408521,2.69922808194526,STAT1
Glycosaminoglycan Biosynthetic Process (GO:0006024),1/58,0.336970180744553,0.429078403356731,0,0,2.48145363408521,2.69922808194526,HS3ST1
Metal Ion Transport (GO:0030001),2/171,0.339946484555456,0.430388619386247,0,0,1.67638670128986,1.80876605084278,KCNC4;KCNN4
Negative Regulation Of Protein-Containing Complex Assembly (GO:0031333),1/59,0.341658128248168,0.430388619386247,0,0,2.43854679802956,2.61886432868888,JAM3
Regulation Of miRNA Transcription (GO:1902893),1/59,0.341658128248168,0.430388619386247,0,0,2.43854679802956,2.61886432868888,MYB
Regulation Of Multicellular Organismal Development (GO:2000026),1/59,0.341658128248168,0.430388619386247,0,0,2.43854679802956,2.61886432868888,OAS2
Cellular Response To Chemokine (GO:1990869),1/59,0.341658128248168,0.430388619386247,0,0,2.43854679802956,2.61886432868888,ZC3H12A
Glucose Metabolic Process (GO:0006006),1/59,0.341658128248168,0.430388619386247,0,0,2.43854679802956,2.61886432868888,OAS1
Positive Regulation Of Proteolysis (GO:0045862),1/59,0.341658128248168,0.430388619386247,0,0,2.43854679802956,2.61886432868888,ZC3H12A
Regulation Of Cell Death (GO:0010941),1/59,0.341658128248168,0.430388619386247,0,0,2.43854679802956,2.61886432868888,WNT16
Generation Of Neurons (GO:0048699),2/172,0.342511833573578,0.430887213091895,0,0,1.66644096487516,1.78550662418664,CDK6;WNT16
Response To Light Stimulus (GO:0009416),1/60,0.346313163053803,0.434507581911504,0,0,2.39709443099274,2.54190726287583,TNFSF13B
protein-DNA Complex Organization (GO:0071824),1/60,0.346313163053803,0.434507581911504,0,0,2.39709443099274,2.54190726287583,SATB1
Regulation Of Cell Cycle (GO:0051726),3/298,0.350893044236816,0.438552880705728,0,0,1.44170965364775,1.50986477519074,CDK6;MX2;TNFSF13B
Positive Regulation Of Interleukin-8 Production (GO:0032757),1/61,0.350935514528601,0.438552880705728,0,0,2.35702380952381,2.46816406221432,TLR7
Positive Regulation Of Organelle Assembly (GO:1902117),1/61,0.350935514528601,0.438552880705728,0,0,2.35702380952381,2.46816406221432,TAPT1
Positive Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901992),1/63,0.360083077369398,0.448792285833912,0,0,2.28076036866359,2.32961540454479,TNFSF13B
Regulation Of Cellular Catabolic Process (GO:0031329),1/63,0.360083077369398,0.448792285833912,0,0,2.28076036866359,2.32961540454479,LAMP3
Regulation Of Secretion By Cell (GO:1903530),1/64,0.364608739740155,0.45203797641039,0,0,2.24444444444444,2.26448833494352,MYOF
Response To Metal Ion (GO:0010038),1/64,0.364608739740155,0.45203797641039,0,0,2.24444444444444,2.26448833494352,PLSCR1
Protein N-linked Glycosylation (GO:0006487),1/64,0.364608739740155,0.45203797641039,0,0,2.24444444444444,2.26448833494352,MGAT3
Negative Regulation Of Cell Death (GO:0060548),1/64,0.364608739740155,0.45203797641039,0,0,2.24444444444444,2.26448833494352,WNT16
Canonical Wnt Signaling Pathway (GO:0060070),1/65,0.36910262072547,0.455807829531059,0,0,2.20926339285714,2.20192989470938,WNT16
Monocarboxylic Acid Biosynthetic Process (GO:0072330),1/65,0.36910262072547,0.455807829531059,0,0,2.20926339285714,2.20192989470938,GATM
Regulation Of Cell-Matrix Adhesion (GO:0001952),1/65,0.36910262072547,0.455807829531059,0,0,2.20926339285714,2.20192989470938,CDK6
Peptidyl-Threonine Modification (GO:0018210),1/66,0.373564941947523,0.46011074656102,0,0,2.17516483516484,2.1418052358706,GALNTL6
Response To Reactive Oxygen Species (GO:0000302),1/66,0.373564941947523,0.46011074656102,0,0,2.17516483516484,2.1418052358706,AGAP3
Negative Regulation Of Macromolecule Metabolic Process (GO:0010605),2/186,0.378066258153515,0.465046207741775,0,0,1.53855176728183,1.49652747599024,ZC3H12A;PARP9
Positive Regulation Of DNA-templated Transcription (GO:0045893),10/1243,0.380212209370174,0.467075312033072,0,0,1.15314846802003,1.1151242464927,KCNH2;PLSCR1;STAT1;MYB;ZC3H12A;IRF7;CD38;BRCA2;PARP9;IER5
Skin Development (GO:0043588),1/68,0.382395783939176,0.46914528381586,0,0,2.11002132196162,2.0283616465859,WNT16
Phagocytosis (GO:0006909),1/69,0.386764740263967,0.473271288151357,0,0,2.07888655462185,1.97481474353214,ITGAM
Positive Regulation Of Phosphatidylinositol 3-Kinase Signaling (GO:0014068),1/69,0.386764740263967,0.473271288151357,0,0,2.07888655462185,1.97481474353214,WNT16
Negative Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001237),1/70,0.391103007983409,0.476720117244026,0,0,2.04865424430642,1.92324445331334,IFI6
Protein K48-linked Ubiquitination (GO:0070936),1/70,0.391103007983409,0.476720117244026,0,0,2.04865424430642,1.92324445331334,IFI27
Regulation Of Notch Signaling Pathway (GO:0008593),1/70,0.391103007983409,0.476720117244026,0,0,2.04865424430642,1.92324445331334,IL6ST
Regulation Of Cilium Assembly (GO:1902017),1/71,0.395410801162509,0.480105243734091,0,0,2.01928571428571,1.87355396841291,TAPT1
Cell-Cell Junction Assembly (GO:0007043),1/71,0.395410801162509,0.480105243734091,0,0,2.01928571428571,1.87355396841291,JAM3
Protein Autoubiquitination (GO:0051865),1/71,0.395410801162509,0.480105243734091,0,0,2.01928571428571,1.87355396841291,BRCA2
Response To Ionizing Radiation (GO:0010212),1/72,0.399688332364652,0.484049833661696,0,0,1.9907444668008,1.82565243561972,BRCA2
Negative Regulation Of Cell Adhesion (GO:0007162),1/72,0.399688332364652,0.484049833661696,0,0,1.9907444668008,1.82565243561972,JAM3
Regulation Of Programmed Cell Death (GO:0043067),2/195,0.400506843265546,0.484417660042261,0,0,1.46613486412942,1.34154921221641,GLS2;STAT1
Negative Regulation Of Nucleic Acid-Templated Transcription (GO:1903507),4/456,0.401469439655886,0.484826020017241,0,0,1.25360118855371,1.14406636051219,GFI1;MYB;CD38;SOX7
Cellular Response To Reactive Oxygen Species (GO:0034614),1/73,0.403935812639231,0.484826020017241,0,0,1.96299603174603,1.77945451542945,AGAP3
Ubiquitin-Dependent ERAD Pathway (GO:0030433),1/73,0.403935812639231,0.484826020017241,0,0,1.96299603174603,1.77945451542945,MAN1A1
Protein Tetramerization (GO:0051262),1/73,0.403935812639231,0.484826020017241,0,0,1.96299603174603,1.77945451542945,GBP5
Monocarboxylic Acid Transport (GO:0015718),1/73,0.403935812639231,0.484826020017241,0,0,1.96299603174603,1.77945451542945,SLC16A4
Regulation Of Rho Protein Signal Transduction (GO:0035023),1/73,0.403935812639231,0.484826020017241,0,0,1.96299603174603,1.77945451542945,LPAR6
Golgi Vesicle Transport (GO:0048193),2/197,0.405443440046688,0.486015639597368,0,0,1.45095000922339,1.30987979441223,PGAP1;KIF1C
Negative Regulation Of Neuron Apoptotic Process (GO:0043524),1/74,0.408153451620861,0.488641727703855,0,0,1.93600782778865,1.73487997894906,IL6ST
Regulation Of Fat Cell Differentiation (GO:0045598),1/75,0.412341457464369,0.491778595024045,0,0,1.90974903474903,1.69185333992713,ZC3H12A
Negative Regulation Of Phosphorylation (GO:0042326),1/75,0.412341457464369,0.491778595024045,0,0,1.90974903474903,1.69185333992713,ZC3H12A
Positive Regulation Of Neurogenesis (GO:0050769),1/75,0.412341457464369,0.491778595024045,0,0,1.90974903474903,1.69185333992713,HAPLN3
Wnt Signaling Pathway (GO:0016055),1/76,0.416500036940043,0.495482344830063,0,0,1.88419047619048,1.65030351697882,WNT16
Positive Regulation Of Interleukin-6 Production (GO:0032755),1/76,0.416500036940043,0.495482344830063,0,0,1.88419047619048,1.65030351697882,TLR7
Sphingolipid Biosynthetic Process (GO:0030148),1/77,0.420629395273759,0.498504106993208,0,0,1.8593045112782,1.61016352499538,CERS6
Monoatomic Cation Homeostasis (GO:0055080),1/77,0.420629395273759,0.498504106993208,0,0,1.8593045112782,1.61016352499538,KCNH2
Negative Regulation Of Blood Vessel Morphogenesis (GO:2000181),1/77,0.420629395273759,0.498504106993208,0,0,1.8593045112782,1.61016352499538,STAT1
Negative Regulation Of Gene Expression (GO:0010629),3/336,0.423265740454492,0.500840453547423,0,0,1.2747094921008,1.09593794754471,ZC3H12A;EIF2AK2;PARP9
Negative Regulation Of Protein Modification Process (GO:0031400),1/78,0.424729736377092,0.500840453547423,0,0,1.83506493506494,1.57137019011573,ZC3H12A
Long-Chain Fatty Acid Metabolic Process (GO:0001676),1/78,0.424729736377092,0.500840453547423,0,0,1.83506493506494,1.57137019011573,ABHD6
Proteolysis Involved In Protein Catabolic Process (GO:0051603),1/78,0.424729736377092,0.500840453547423,0,0,1.83506493506494,1.57137019011573,ISG15
Regulation Of Cyclin-Dependent Protein Serine/Threonine Kinase Activity (GO:0000079),1/79,0.428801262690408,0.501868144517007,0,0,1.81144688644689,1.53386388944917,HERC5
Response To Insulin (GO:0032868),1/79,0.428801262690408,0.501868144517007,0,0,1.81144688644689,1.53386388944917,IRS1
Positive Regulation Of Catabolic Process (GO:0009896),1/79,0.428801262690408,0.501868144517007,0,0,1.81144688644689,1.53386388944917,TNFSF13B
Vesicle Fusion (GO:0006906),1/79,0.428801262690408,0.501868144517007,0,0,1.81144688644689,1.53386388944917,SAMD9
Positive Regulation Of Protein Localization To Membrane (GO:1905477),1/79,0.428801262690408,0.501868144517007,0,0,1.81144688644689,1.53386388944917,ITGAM
Positive Regulation Of Protein Modification By Small Protein Conjugation Or Removal (GO:1903322),1/79,0.428801262690408,0.501868144517007,0,0,1.81144688644689,1.53386388944917,ZC3H12A
Negative Regulation Of Cell Differentiation (GO:0045596),2/207,0.429829048267424,0.502446129713846,0,0,1.37947008247061,1.16477999663512,CDK6;MYB
Regulation Of Protein Localization To Plasma Membrane (GO:1903076),1/80,0.432844175290293,0.504716690146426,0,0,1.78842676311031,1.49758831046904,GBP1
Wound Healing (GO:0042060),1/80,0.432844175290293,0.504716690146426,0,0,1.78842676311031,1.49758831046904,MYOF
Regulation Of Interleukin-8 Production (GO:0032677),1/81,0.436858673848277,0.508767341697065,0,0,1.76598214285714,1.46249023002305,TLR7
Positive Regulation Of Cell Population Proliferation (GO:0008284),4/483,0.444143825230782,0.516103366786318,0,0,1.18129314417201,0.958745593851844,CDK6;IRS1;STAT1;IL6ST
Calcium Ion Transmembrane Import Into Cytosol (GO:0097553),1/83,0.444803220471524,0.516103366786318,0,0,1.72273519163763,1.39562791124574,PLCB3
Phospholipase C-activating G Protein-Coupled Receptor Signaling Pathway (GO:0007200),1/83,0.444803220471524,0.516103366786318,0,0,1.72273519163763,1.39562791124574,LPAR6
Nuclear-Transcribed mRNA Catabolic Process (GO:0000956),1/85,0.452636472440617,0.522614626462112,0,0,1.68154761904762,1.33290556574126,ZC3H12A
Positive Regulation Of Endothelial Cell Migration (GO:0010595),1/85,0.452636472440617,0.522614626462112,0,0,1.68154761904762,1.33290556574126,ZC3H12A
Positive Regulation Of Protein Localization (GO:1903829),1/85,0.452636472440617,0.522614626462112,0,0,1.68154761904762,1.33290556574126,PARP9
Negative Regulation Of Cell Cycle (GO:0045786),1/85,0.452636472440617,0.522614626462112,0,0,1.68154761904762,1.33290556574126,CDK6
Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901990),1/86,0.456511847532617,0.525798835407824,0,0,1.66168067226891,1.30299132308003,CDK6
Negative Regulation Of Angiogenesis (GO:0016525),1/86,0.456511847532617,0.525798835407824,0,0,1.66168067226891,1.30299132308003,STAT1
Regulation Of Insulin Secretion (GO:0050796),1/87,0.460359977859109,0.529582810715675,0,0,1.64227574750831,1.27398972060564,IRS1
Regulation Of Endothelial Cell Migration (GO:0010594),1/88,0.464181053534427,0.531380013839289,0,0,1.62331691297209,1.2458642404389,ZC3H12A
Negative Regulation Of Neuron Death (GO:1901215),1/88,0.464181053534427,0.531380013839289,0,0,1.62331691297209,1.2458642404389,IL6ST
Positive Regulation Of Cell Adhesion (GO:0045785),1/88,0.464181053534427,0.531380013839289,0,0,1.62331691297209,1.2458642404389,FBLN2
Positive Regulation Of Plasma Membrane Bounded Cell Projection Assembly (GO:0120034),1/88,0.464181053534427,0.531380013839289,0,0,1.62331691297209,1.2458642404389,TAPT1
ERAD Pathway (GO:0036503),1/89,0.467975263486317,0.534423207452214,0,0,1.60478896103896,1.21858019332614,MAN1A1
Cellular Response To Peptide Hormone Stimulus (GO:0071375),1/89,0.467975263486317,0.534423207452214,0,0,1.60478896103896,1.21858019332614,IRS1
Protein Phosphorylation (GO:0006468),4/500,0.470563351821736,0.536727410986974,0,0,1.1398045679303,0.859212814997079,CDK6;EIF2AK2;SGK3;TLR7
Regulation Of Phosphatidylinositol 3-Kinase Signaling (GO:0014066),1/90,0.471742795223647,0.537421271556237,0,0,1.58667736757624,1.192104609265,WNT16
Protein Modification By Small Protein Conjugation (GO:0032446),3/364,0.474861290522618,0.539722905605992,0,0,1.17415392026978,0.874430628512107,HERC5;ISG15;HERC6
Regulation Of Epithelial Cell Proliferation (GO:0050678),1/91,0.475483835013143,0.539722905605992,0,0,1.56896825396825,1.16640613444085,CDK6
Positive Regulation Of Binding (GO:0051099),1/91,0.475483835013143,0.539722905605992,0,0,1.56896825396825,1.16640613444085,PARP9
B Cell Activation (GO:0042113),1/92,0.479198567756622,0.542630387796608,0,0,1.55164835164835,1.1414549363319,CD70
Positive Regulation Of Protein Catabolic Process (GO:0045732),1/92,0.479198567756622,0.542630387796608,0,0,1.55164835164835,1.1414549363319,TNFSF13B
Regulation Of Endothelial Cell Proliferation (GO:0001936),1/93,0.482887177197242,0.544840328228543,0,0,1.5347049689441,1.11722261428638,STAT1
Protein O-linked Glycosylation (GO:0006493),1/93,0.482887177197242,0.544840328228543,0,0,1.5347049689441,1.11722261428638,GALNTL6
Negative Regulation Of Amide Metabolic Process (GO:0034249),1/93,0.482887177197242,0.544840328228543,0,0,1.5347049689441,1.11722261428638,EIF2AK2
Sphingolipid Metabolic Process (GO:0006665),1/94,0.486549845800751,0.547659575237448,0,0,1.51812596006144,1.09368211723452,CERS6
Muscle Contraction (GO:0006936),1/94,0.486549845800751,0.547659575237448,0,0,1.51812596006144,1.09368211723452,MYOF
Positive Regulation Of Epithelial Cell Migration (GO:0010634),1/95,0.490186754599399,0.550436439233931,0,0,1.50189969604863,1.07080766704796,ZC3H12A
Recombinational Repair (GO:0000725),1/95,0.490186754599399,0.550436439233931,0,0,1.50189969604863,1.07080766704796,BRCA2
Positive Regulation Of GTPase Activity (GO:0043547),2/234,0.492903386031375,0.552827278016119,0,0,1.21725378318035,0.861136567351377,SGSM1;AGAP3
Monocarboxylic Acid Metabolic Process (GO:0032787),1/97,0.497384011210361,0.557188517320178,0,0,1.47046130952381,1.02695972779905,GATM
Negative Regulation Of Macromolecule Biosynthetic Process (GO:0010558),1/98,0.500944714995303,0.559844390511378,0,0,1.45522827687776,1.00594041951509,EIF2AK2
Positive Regulation Of Cold-Induced Thermogenesis (GO:0120162),1/98,0.500944714995303,0.559844390511378,0,0,1.45522827687776,1.00594041951509,GATM
Response To UV (GO:0009411),1/100,0.507991154544595,0.566374024201972,0,0,1.42568542568543,0.965604255328444,TNFSF13B
Protein Complex Oligomerization (GO:0051259),1/100,0.507991154544595,0.566374024201972,0,0,1.42568542568543,0.965604255328444,ZC3H12A
Hemopoiesis (GO:0030097),1/101,0.511477238962841,0.569585895697082,0,0,1.41135714285714,0.946247491798595,MYB
Regulation Of Protein Secretion (GO:0050708),1/102,0.514938796865765,0.572762893440526,0,0,1.3973125884017,0.927406462486914,RSAD2
Positive Regulation Of Multicellular Organismal Process (GO:0051240),3/387,0.515640257004719,0.572865976200048,0,0,1.10252490942029,0.730252889773001,GATM;EIF2AK2;TAPT1
Inorganic Cation Import Across Plasma Membrane (GO:0098659),1/103,0.518375999637542,0.575226197710998,0,0,1.38354341736695,0.909063334261004,KCNH2
Positive Regulation Of Kinase Activity (GO:0033674),1/104,0.521789017437466,0.578331525805248,0,0,1.37004160887656,0.891201043160501,TRAF4
Regulation Of Neuron Apoptotic Process (GO:0043523),1/105,0.525178019212804,0.580038164412264,0,0,1.35679945054945,0.873803254503398,IL6ST
Intrinsic Apoptotic Signaling Pathway (GO:0097193),1/105,0.525178019212804,0.580038164412264,0,0,1.35679945054945,0.873803254503398,IFI6
Negative Regulation Of MAPK Cascade (GO:0043409),1/105,0.525178019212804,0.580038164412264,0,0,1.35679945054945,0.873803254503398,GBP1
Regulation Of Cellular Response To Stress (GO:0080135),1/107,0.53188464475594,0.586069614420772,0,0,1.33106469002695,0.840339268916045,BRCA2
Negative Regulation Of Translation (GO:0017148),1/107,0.53188464475594,0.586069614420772,0,0,1.33106469002695,0.840339268916045,EIF2AK2
Positive Regulation Of Metabolic Process (GO:0009893),1/108,0.535202600528085,0.588347718571177,0,0,1.31855807743658,0.824243722693423,GATM
Glycerophospholipid Biosynthetic Process (GO:0046474),1/108,0.535202600528085,0.588347718571177,0,0,1.31855807743658,0.824243722693423,PLSCR1
Negative Regulation Of Developmental Process (GO:0051093),1/109,0.538497204499392,0.588531787960427,0,0,1.30628306878307,0.808553915542499,CDK6
Cell-Matrix Adhesion (GO:0007160),1/109,0.538497204499392,0.588531787960427,0,0,1.30628306878307,0.808553915542499,ITGAM
Cellular Response To Salt (GO:1902075),1/109,0.538497204499392,0.588531787960427,0,0,1.30628306878307,0.808553915542499,ZC3H12A
Positive Regulation Of Cysteine-Type Endopeptidase Activity Involved In Apoptotic Process (GO:0043280),1/109,0.538497204499392,0.588531787960427,0,0,1.30628306878307,0.808553915542499,SOX7
Regulation Of Wnt Signaling Pathway (GO:0030111),1/109,0.538497204499392,0.588531787960427,0,0,1.30628306878307,0.808553915542499,SOX7
RNA Metabolic Process (GO:0016070),1/111,0.545017008686471,0.59358912635876,0,0,1.2824025974026,0.77833922187071,ZC3H12A
Double-Strand Break Repair Via Homologous Recombination (GO:0000724),1/111,0.545017008686471,0.59358912635876,0,0,1.2824025974026,0.77833922187071,BRCA2
Mitotic Cell Cycle Phase Transition (GO:0044772),1/111,0.545017008686471,0.59358912635876,0,0,1.2824025974026,0.77833922187071,CDK6
Calcium Ion Transport (GO:0006816),1/112,0.548242531866743,0.595723120654278,0,0,1.27078507078507,0.763789499192229,KCNN4
Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071900),1/112,0.548242531866743,0.595723120654278,0,0,1.27078507078507,0.763789499192229,HERC5
Regulation Of Protein Ubiquitination (GO:0031396),1/113,0.551445349166098,0.598512195577046,0,0,1.259375,0.749595792679056,ISG15
Endoplasmic Reticulum To Golgi Vesicle-Mediated Transport (GO:0006888),1/115,0.557783499983637,0.604693863461524,0,0,1.23715538847118,0.722231997299284,PGAP1
Positive Regulation Of Signal Transduction (GO:0009967),2/266,0.561757509416806,0.60830128465042,0,0,1.06796381076957,0.615878710328839,IRS1;IL6ST
Positive Regulation Of Cell Cycle Process (GO:0090068),1/118,0.567124364379454,0.613406927449502,0,0,1.20525030525031,0.683589844735701,PLSCR1
Positive Regulation Of Apoptotic Process (GO:0043065),2/270,0.569885563351892,0.614607996477292,0,0,1.05180929882959,0.591453093959961,ZC3H12A;IFIT2
Regulation Of Protein Kinase Activity (GO:0045859),1/119,0.570194241152684,0.614607996477292,0,0,1.19497578692494,0.671311349313026,TRAF4
Regulation Of Protein-Containing Complex Assembly (GO:0043254),1/119,0.570194241152684,0.614607996477292,0,0,1.19497578692494,0.671311349313026,EIF2AK2
Regulation Of Protein Catabolic Process (GO:0042176),1/122,0.579274768252407,0.621547955445285,0,0,1.16517119244392,0.636158253750004,TNFSF13B
Positive Regulation Of Macromolecule Biosynthetic Process (GO:0010557),1/122,0.579274768252407,0.621547955445285,0,0,1.16517119244392,0.636158253750004,IRS1
Protein Localization To Nucleus (GO:0034504),1/122,0.579274768252407,0.621547955445285,0,0,1.16517119244392,0.636158253750004,GBP2
Receptor-Mediated Endocytosis (GO:0006898),1/122,0.579274768252407,0.621547955445285,0,0,1.16517119244392,0.636158253750004,ITGAM
Organonitrogen Compound Biosynthetic Process (GO:1901566),1/123,0.582259076575448,0.623328545002841,0,0,1.15556206088993,0.624973932573338,CERS6
Modulation Of Chemical Synaptic Transmission (GO:0050804),1/123,0.582259076575448,0.623328545002841,0,0,1.15556206088993,0.624973932573338,MYOF
Enzyme-Linked Receptor Protein Signaling Pathway (GO:0007167),1/124,0.585222365485538,0.625407924750898,0,0,1.14610917537747,0.614043339440873,IL6ST
Phosphorylation (GO:0016310),3/429,0.585530692566993,0.625407924750898,0,0,0.991681975913452,0.530784564631594,CDK6;EIF2AK2;SGK3
Regulation Of Cell Migration (GO:0030334),3/434,0.593418527398624,0.633114324582886,0,0,0.979925350549783,0.511379285969956,IFITM1;MGAT3;SGK3
Central Nervous System Development (GO:0007417),2/283,0.595551030203803,0.634669897419908,0,0,1.00248342251466,0.519555279739318,ITGAM;AIM2
Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169),2/284,0.5974775953757,0.636002734444042,0,0,0.998877493749681,0.51446035923095,IRS1;GAB1
Protein Homooligomerization (GO:0051260),1/129,0.599728627507678,0.636957831246868,0,0,1.10106026785714,0.562947906566481,GBP5
Protein Targeting (GO:0006605),1/129,0.599728627507678,0.636957831246868,0,0,1.10106026785714,0.562947906566481,MAN1A1
DNA Repair (GO:0006281),2/291,0.610772521537596,0.647435563570918,0,0,0.97433471907595,0.480376923035482,BRCA2;PARP9
Negative Regulation Of Cell Motility (GO:2000146),1/133,0.610970011106243,0.647435563570918,0,0,1.06747835497836,0.525954487692379,IFITM1
Regulation Of Protein Kinase B Signaling (GO:0051896),1/136,0.619194814107491,0.655413183436613,0,0,1.04359788359788,0.500233337895233,AIM2
Regulation Of Nucleic Acid-Templated Transcription (GO:1903506),3/452,0.621010367750762,0.656596355116255,0,0,0.939769536167328,0.447713257122156,MYB;BRCA2;SOX7
Regulation Of Intracellular Signal Transduction (GO:1902531),2/297,0.621902305465783,0.656801424739957,0,0,0.954225094500671,0.453230453258734,TRAF4;GBP1
Positive Regulation Of Protein Kinase Activity (GO:0045860),1/145,0.642847464279891,0.678160833954459,0,0,0.977926587301587,0.432094718942066,TRAF4
Regulation Of Cold-Induced Thermogenesis (GO:0120161),1/146,0.645383768531312,0.679313340254994,0,0,0.971133004926108,0.425268999033322,GATM
Neuron Projection Morphogenesis (GO:0048812),1/146,0.645383768531312,0.679313340254994,0,0,0.971133004926108,0.425268999033322,BTBD3
Negative Regulation Of Protein Metabolic Process (GO:0051248),1/147,0.647902188082541,0.681202188810805,0,0,0.964432485322896,0.418578684310164,EIF2AK2
Negative Regulation Of Protein Phosphorylation (GO:0001933),1/149,0.652885873021206,0.68474047531875,0,0,0.951303088803089,0.405590867126603,ZC3H12A
Skeletal System Development (GO:0001501),1/149,0.652885873021206,0.68474047531875,0,0,0.951303088803089,0.405590867126603,ANKH
Positive Regulation Of Transcription By RNA Polymerase II (GO:0045944),6/938,0.6534505279875,0.68474047531875,0,0,0.902575107296137,0.384035285162626,PLSCR1;STAT1;MYB;ZC3H12A;IRF7;IER5
Cellular Response To Organic Cyclic Compound (GO:0071407),1/152,0.660230367481089,0.691075390211018,0,0,0.932261116367077,0.387043550483856,ZC3H12A
Regulation Of Cellular Component Organization (GO:0051128),1/153,0.662644078084935,0.692831197197693,0,0,0.926080827067669,0.381098252283331,SGK3
Epithelium Development (GO:0060429),1/154,0.665040762504861,0.69456532465824,0,0,0.919981325863679,0.375266770438806,STAT1
Peptide Biosynthetic Process (GO:0043043),1/158,0.674459610049332,0.702842185001574,0,0,0.896360327570519,0.353025676523839,CARNS1
Peptidyl-Serine Phosphorylation (GO:0018105),1/158,0.674459610049332,0.702842185001574,0,0,0.896360327570519,0.353025676523839,SGK3
Protein Autophosphorylation (GO:0046777),1/162,0.683615429896867,0.710808971859615,0,0,0.873913043478261,0.332401352390689,EIF2AK2
Mitochondrion Organization (GO:0007005),1/162,0.683615429896867,0.710808971859615,0,0,0.873913043478261,0.332401352390689,IFIT2
Negative Regulation Of Cell Migration (GO:0030336),1/163,0.685864145990657,0.712360001520097,0,0,0.86847442680776,0.32748061004831,IFITM1
Peptidyl-Serine Modification (GO:0018209),1/166,0.692515516069426,0.718475303882392,0,0,0.852554112554113,0.313249383874639,SGK3
Brain Development (GO:0007420),1/169,0.699027030029236,0.724432197420167,0,0,0.837202380952381,0.299773597165639,AIM2
Cell-Cell Adhesion Via Plasma-Membrane Adhesion Molecules (GO:0098742),1/172,0.705401608021848,0.730234227886204,0,0,0.822389306599833,0.287003984194858,ITGAM
Neuron Differentiation (GO:0030182),1/173,0.707496533101863,0.731598063350388,0,0,0.817566445182724,0.282896425899954,WNT16
Regulation Of Neuron Projection Development (GO:0010975),1/174,0.709576665720294,0.732139958818856,0,0,0.812799339388935,0.278860669314664,GFI1
Positive Regulation Of Cellular Biosynthetic Process (GO:0031328),1/174,0.709576665720294,0.732139958818856,0,0,0.812799339388935,0.278860669314664,IRS1
Protein Localization (GO:0008104),2/351,0.711235581502499,0.732664360085142,0,0,0.804353651749088,0.274084766290291,MGAT3;JAM3
Positive Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043123),1/175,0.71164210958323,0.732664360085142,0,0,0.808087027914614,0.274895165579796,MID2
Phosphate-Containing Compound Metabolic Process (GO:0006796),1/184,0.72958686969502,0.750318299872146,0,0,0.767993754879001,0.242130641846546,INPP1
Endocytosis (GO:0006897),1/189,0.739072395571056,0.759243585406511,0,0,0.747378419452888,0.225976889428833,ITGAM
Protein Modification Process (GO:0036211),4/711,0.742797284931662,0.762237999041105,0,0,0.790922887909229,0.23516676691043,PGAP1;CDK6;EIF2AK2;SGK3
Regulation Of Signal Transduction (GO:0009966),1/193,0.746422332445087,0.765123545567349,0,0,0.731659226190476,0.21398377151776,PLSCR1
Positive Regulation Of Protein Metabolic Process (GO:0051247),1/196,0.751799537767909,0.769796915168229,0,0,0.72029304029304,0.205489205298883,TNFSF13B
Anterograde Trans-Synaptic Signaling (GO:0098916),1/199,0.757063508301293,0.774344305773388,0,0,0.709271284271284,0.197395967870705,KCNC4
Organic Substance Transport (GO:0071702),1/201,0.760511085124348,0.777025983824117,0,0,0.702107142857143,0.192212075005112,KCNN4
Regulation Of Translation (GO:0006417),1/202,0.762216611915558,0.777923895675207,0,0,0.698578535891969,0.189681184934668,EIF2AK2
Regulation Of MAPK Cascade (GO:0043408),1/204,0.765591568522,0.78052184829816,0,0,0.691625615763547,0.184737664204972,EIF2AK2
Regulation Of Canonical Wnt Signaling Pathway (GO:0060828),1/207,0.77056502266997,0.78474208477537,0,0,0.681449375866852,0.177606994163624,SOX7
Positive Regulation Of Cellular Process (GO:0048522),3/594,0.793523873139851,0.807249691486054,0,0,0.708747149268006,0.163913125192461,IRS1;IL6ST;IER5
Regulation Of Cell Growth (GO:0001558),1/227,0.801146717009071,0.814124255621529,0,0,0.62051201011378,0.137574450825689,SGK3
Chromatin Remodeling (GO:0006338),1/228,0.802564715730628,0.814685434199052,0,0,0.617747010698553,0.135868997695565,SATB1
Negative Regulation Of Multicellular Organismal Process (GO:0051241),1/231,0.806758750848385,0.81806032817708,0,0,0.609596273291925,0.130898974174191,BRCA2
Positive Regulation Of Developmental Process (GO:0051094),1/233,0.809505506600018,0.81996198246568,0,0,0.604279556650246,0.127703428046906,TAPT1
Regulation Of ERK1 And ERK2 Cascade (GO:0070372),1/244,0.823934039443214,0.833679495823725,0,0,0.576601998824221,0.111667511644591,GBP1
Regulation Of Protein Phosphorylation (GO:0001932),1/265,0.848532987151802,0.857647197540113,0,0,0.530167748917749,0.0870781007049691,ZC3H12A
Negative Regulation Of Signal Transduction (GO:0009968),1/267,0.850689648014609,0.858904462212175,0,0,0.526127819548872,0.0850790289658388,IRS1
Chromatin Organization (GO:0006325),1/268,0.85175651664354,0.859059895135661,0,0,0.524130551096843,0.0840991430296469,SATB1
Positive Regulation Of Cell Migration (GO:0030335),1/272,0.855948826844788,0.862363860878957,0,0,0.516288877174486,0.0803059914664976,GAB1
Chemical Synaptic Transmission (GO:0007268),1/273,0.856978377272887,0.86247770375806,0,0,0.514364495798319,0.0793883492173651,KCNC4
Regulation Of DNA-templated Transcription (GO:0006355),10/1922,0.880861465033667,0.88556692157765,0,0,0.71652719665272,0.090894995063463,KCNH2;SATB1;STAT1;GFI1;MYB;IRF7;CD38;BRCA2;PARP9;SOX7
Positive Regulation Of MAPK Cascade (GO:0043410),1/310,0.890344155335235,0.894144984173379,0,0,0.451918631530282,0.0524890835055852,EIF2AK2
Regulation Of Transcription By RNA Polymerase II (GO:0006357),10/2028,0.916347918961405,0.919278669235269,0,0,0.674880275989378,0.0589569755154986,PLSCR1;IFI27;SATB1;STAT1;GFI1;MYB;ZC3H12A;IRF7;PARP9;IER5
Positive Regulation Of Protein Phosphorylation (GO:0001934),1/377,0.932303583011913,0.934289320142929,0,0,0.370117781155015,0.0259440663417514,TRAF4
Vesicle-Mediated Transport (GO:0016192),1/411,0.947034139612457,0.948041622739704,0,0,0.33883275261324,0.0184393245356309,KIF1C
Nervous System Development (GO:0007399),1/433,0.954820557856271,0.954820557856271,0,0,0.321213624338624,0.014850301283356,BTBD3
